Podcasts about co investigator

About the Speaker: Dr. Abigail Chaffin is a Professor of Surgery and Chief of the Division Plastic and Reconstructive Surgery at Tulane University. She is also the Program Director of the Tulane University/Ochsner Clinic Plastic Surgery residency program. She currently serves the Medical Director of the MedCentris Wound Healing Institute at Metairie. Dr. Chaffin is Board-Certified by the American Board of Plastic Surgery and is Board-Certified by the American Board of Surgery. She is also Board-Certified by the American Board of Wound Medicine & Surgery, and the American Board of Wound Healing. Dr. Chaffin is a Fellow of the American College of Surgeons. She is also a Certified Wound Specialist Physician. Due to her clinical and research excellence in wound medicine, she has been honored to be named as a Master of the American Professional Wound Care Association. Dr. Chaffin is a graduate of the University of Michigan, Ann Arbor, where she received a Bachelor's Degree in Biology. She then received M.D. degree at Wayne State University School of Medicine in Detroit, Michigan. After this, she completed a five-year residency in General Surgery at the Wayne State University/Detroit Medical Center program.  She then completed a two-year fellowship in Plastic and Reconstructive Surgery at Tulane University, serving as well as Chief Administrative Resident. Dr. Chaffin has been in practice for over 18 years. She focuses her practice on wound medicine and wound reconstructive surgery, in addition to general reconstructive plastic surgery. She has a particular clinical interest in complex wound surgical reconstruction. She has been honored to receive a Top Doctor award by New Orleans Magazine for the past seven years. As well, she has received the New Orleans Magazine Exceptional Women in Medicine award for the past four years. Dr. Chaffin has published over 65 peer-reviewed publications in wound medicine and plastic surgery. She is a section editor for the ePlasty journal for the reconstructive surgery section. She also serves as an invited peer-reviewer for the Advances in Skin and Wound Care journal, the Journal of Wound Care, and the International Journal of Tissue Repair. She has served as Primary Investigator or Co-Investigator for numerous clinical trials at Tulane University.  She is on the Editorial Board of the International Journal of Tissue Repair. She is an internationally and nationally recognized speaker at scientific conferences, and she frequently serves as a course faculty member and speaker for wound medicine scientific meetings including the Boswick Wound and Burn Symposium, the CAMPs Summit, SIITRAL, and the Symposium on Advanced Wound Care. She is a Board Examiner for the American Board of Plastic Surgery.  She serves as committee chair for several national plastic surgery societies including the American Society of Plastic Surgeons, the Southeastern Society of Plastic and Reconstructive Surgeons, and the American Council of Academic Plastic Surgeons. For ACEPS, she currently serves as Chair of the Research Committee. Dr. Chaffin is currently the Chair of the Assembly of State and Regional Societies for the American Society of Plastic Surgeons, and she is presently serving as a member of the American Society of Plastic Surgeons Board of Directors. Editing and post-production work for this episode was provided by The Podcast Consultant.

Von 17. bis 20. April 2026 fand zum 7. Mal das KTT statt, das Kepler Teleskoptreffen, das unsere Schule gemeinsam mit dem Steirischen Astronomenverein StAV ins Leben gerufen hat und bei dem wir astronomieinteressierte Jugendliche mit Amateurastronomen und Wissenschaftlern aus der Weltraumforschung zusammen, um gemeinsam unter dunklem Nachthimmel die Wunder des Universums zu bestaunen – und in nachmittäglichen Fachvorträgen auch was darüber zu lernen. Und heuer waren beide Bereiche fantastisch, sowohl der Himmel, der uns zwei sehr gute Beobachtungsnächte beschert hat, als auch das Tagesprogramm! Und daraus hört ihr hier einige Ausschnitte, außerdem Interviews mit einigen der Vortragenden und Teilnehmer:innen. Zum Einstieg am Freitag gab uns Frau Dr. Ramona Augustin vom AIP, dem Leibnitz Institut für Astrophysik Potsdam, einen spannenden Onlinevortrag über das zirkumgalaktische Medium, zu dem sie forscht. Aufmerksam wurden wir auf sie durch ihr kürzlich erschienenes Video zu diesem Thema auf dem Kanal Urknall, Weltall und das Leben. Dr. Bruno Besser vom Grazer Institut für Weltraumforschung IWF der Österreichischen Akademie der Wissenschaften hatte dann als Kontrapunkt ein ganz regionales Thema für uns, einen Blick in die Geschichte der Astronomie in der Steiermark. Dave Gloistein vom StAV lieferte uns in wundervollem British English augenzwinkernd den nachvollziehbaren Beweis, dass auf der Erde Aliens leben. Dr. Thomas Klügel vom geodätischen Observatorium Wettzell (D) sprach unter anderem von der Technik der Entfernungsmessung zum Mond mittels Laserranging und vermittelte uns eindrucksvoll, wie spannend Geodäsie sein kann und in welch unerwarteten Bereichen sie angewandt werden könnte (Gravitationswellendedektion!). Und Nico Lampl vom Universitätsobservatorium Lustbühel der Uni Graz präsentierte seine Bachelorarbeit, in der er einen faszinierenden Zeiss-Refraktor wieder verwendbar machen wird. Das Gerät mit dem etwas gruseligen Namen „Ballistische Messkammer“ (BMK) wurde eigentlich einst gebaut, um Satellitenbewegungen zu vermessen, hat ein riesiges Gesichtsfeld von im Prinzip 20° am Himmel und existiert nur zweimal auf der Welt. Das Schwestergerät war einst in Wettzell im geodätischen Observatorium und ist nun in Chile in der Atacamawüste, um mit einem riesigen 10x10cm Kamerachip das Beobachtungsfeld des Weltraumteleskops PLATO vorzubeobachten (Projektleiter ist übrigens ein Grazer Astronom, Dr. Jörg Weingrill). Mit Dr. Szilárd Csizmadia, eigentlich Exoplanetenforscher vom DLR Berlin, aber auch Obmann des ungarischen Amateurastronomievereins VCSE, tauchen wir ein bisschen in die Geschichte der Amateurastronomie ein, und mit DI Gerhard Paar von Joanneum Research Graz geht es dann in die Sonnensystemforschung: er ist Co-Investigator der Mastcam-Z-Stereokamera auf dem Marsrover Perseverance und hat die 3D-Visualisierung entwickelt, die auch auf der HERA-Mission zum Asteroiden Dimorphos verwendet werden wird, und gab uns dazu einige Einblicke. Den Schlusspunkt unserer Vorträge bildete ein Doppelvortrag von Dr. Örs Hunor Detre, einer der Hauptentwickler des Instruments MIRI am James Webb Space Telescope, mit einem Blick hinter die Kulissen seiner Arbeit bei der NASA für das JWST und seiner aktuellen Tätigkeit als Wissenschaftsvermittler in der er neben dem CanSatLab in Ungarn auch erfolgreich ein Projekt gestartet hat, bei dem Schüler:innen tatsächlich Instrumente für einen echten Cubesat entwickeln konnten, der nun im Erdorbit ist. Schließlich kommen auch noch die Stimmen der Teilnehmer:innen nicht zu kurz! Insbesondere habe ich Thomas Holzhäuser von der Keplergesellschaft Weil der Stadt noch zum Interview gebeten.

In our March episode, we truly celebrated National Kidney Month with Dr. Kristin Meliambro, an Associate Professor in the Department of Medicine at the Icahn School of Medicine at Mount Sinai. Dr. Meliambro discussed the many vital jobs kidneys perform, the causes and symptoms of kidney disease, and preventive measures that can help keep them healthy. In this month's Key Note, Dr. Meliambro walks us through the latest innovations that are making dialysis – the necessary treatment for those living with Stage 5 kidney disease – more manageable.   The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. Find out where your health stands by making an appointment with your primary care physician. Don't have one? Find one at our Provider Directory: www.1199SEIUBenefits.org/find-a-provider. Visit the Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. Get to know your numbers at www.1199SEIUBenefits.org/healthyhearts. Need support managing chronic conditions such as type 2 diabetes, hypertension or overweight? Learn about our partnerships: visit www.1199SEIUBenefits.org/the-choice-is-yours/ Browse healthy recipes and meal-prep tips at 1199SEIUBenefits.org/food-as-medicine. For additional information and support, visit the National Kidney Foundation website, at Kidney.org, and the American Association of Kidney Patients, at www.aakp.org. For information about kidney donation, visit the Nation Kidney Registry page at KidneyRegistry.com Get inspired by fellow members through our Members' Voices series: 1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on building healthy meals, managing stress and more: 1199SEIUBenefits.org/videos. Visit our YouTube channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: 1199SEIUBenefits.org/wellnessevents. Guest Bio Kristin Meliambro, MD, is an Associate Professor in the Department of Medicine, Division of Nephrology at the Icahn School of Medicine at Mount Sinai. She earned her medical degree from the Icahn School of Medicine at Mount Sinai, and she completed both her internal medicine residency and clinical and research nephrology fellowships at the Mount Sinai Hospital. In addition to treating patients with a wide range of kidney diseases in diverse clinical settings, Dr. Meliambro is an NIH-funded physician-investigator who conducts basic and translational research with a focus on mechanisms of kidney podocyte injury and novel disease therapies. She is the co-Director of the Nephrology Division's Renal Biorepository, which banks biological specimens and collects clinical data from patients starting at the time of kidney biopsy and continuing longitudinally. She also actively participates as a PI and Co-Investigator in clinical trials testing novel agents for glomerular diseases. Dr. Meliambro also has a strong record of research mentorship of Associate Researchers and graduate/medical students in her lab, the majority of whom have been women and from under-represented minorities in science and medicine. Dr. Meliambro sees patients with a variety of kidney diseases, and she has a particular clinical interest in glomerular diseases. Her clinical responsibilities include the care of outpatients at the Mount Sinai Doctors nephrology practice, hemodialysis patients at Central Park Dialysis Center and inpatients at the Mount Sinai Hospital, where she also teaches and supervises nephrology fellows on the inpatient nephrology services.

This National Kidney Month, we celebrate the unsung heroes of the human body. Kidneys do so much more than filter blood (they've been described as the body's “cleaning crew” and “inventory managers”), so keeping them functioning well is vital to our overall health. Joining us to sing the praises of kidneys – and learn how to keep them healthy – is Dr. Kristin Meliambro, an Associate Professor in the Department of Medicine, Division of Nephrology at the Icahn School of Medicine at Mount Sinai. Dr. Meliambro walks us through the many essential jobs kidneys do for us and breaks down the various causes of kidney disease. She also shares practical lifestyle habits that support long-term kidney health.   The Takeaway We want to hear from you! Please complete our survey: org/member-feedback. Drop us a line at our social media channels: Facebook// Instagram // YouTube. Find out where your health stands by making an appointment with your primary care physician. Don't have one? Find one at our Provider Directory: www.1199SEIUBenefits.org/find-a-provider. Visit the Healthy Living Resource Center for wellness tips, information and resources; 1199SEIUBenefits.org/healthyliving. Get to know your numbers at www.1199SEIUBenefits.org/healthyhearts. Need support managing chronic conditions such as type 2 diabetes, hypertension or overweight? Learn about our partnerships: visit www.1199SEIUBenefits.org/the-choice-is-yours/ Browse healthy recipes and meal-prep tips at 1199SEIUBenefits.org/food-as-medicine. For additional information and support, visit the National Kidney Foundation website, at Kidney.org, and the American Association of Kidney Patients, at www.aakp.org. For information about kidney donation, visit the Nation Kidney Registry page at KidneyRegistry.com Get inspired by fellow members through our Members' Voices series: 1199SEIUBenefits.org/healthyliving/membervoices. Stop by our Benefits Channel to join webinars on building healthy meals, managing stress and more: 1199SEIUBenefits.org/videos. Visit our YouTube channel to view a wide collection of healthy living videos: youtube.com/@1199SEIUBenefitFunds/playlists. Sample our wellness classes to exercise body and mind: 1199SEIUBenefits.org/wellnessevents.   Guest Bio Kristin Meliambro, MD, is an Associate Professor in the Department of Medicine, Division of Nephrology at the Icahn School of Medicine at Mount Sinai. She earned her medical degree from the Icahn School of Medicine at Mount Sinai, and she completed both her internal medicine residency and clinical and research nephrology fellowships at the Mount Sinai Hospital. In addition to treating patients with a wide range of kidney diseases in diverse clinical settings, Dr. Meliambro is an NIH-funded physician-investigator who conducts basic and translational research with a focus on mechanisms of kidney podocyte injury and novel disease therapies. She is the co-Director of the Nephrology Division's Renal Biorepository, which banks biological specimens and collects clinical data from patients starting at the time of kidney biopsy and continuing longitudinally. She also actively participates as a PI and Co-Investigator in clinical trials testing novel agents for glomerular diseases. Dr. Meliambro also has a strong record of research mentorship of Associate Researchers and graduate/medical students in her lab, the majority of whom have been women and from under-represented minorities in science and medicine. Dr. Meliambro sees patients with a variety of kidney diseases, and she has a particular clinical interest in glomerular diseases. Her clinical responsibilities include the care of outpatients at the Mount Sinai Doctors nephrology practice, hemodialysis patients at Central Park Dialysis Center and inpatients at the Mount Sinai Hospital, where she also teaches and supervises nephrology fellows on the inpatient nephrology services.

In this introductory episode, Professor Helen Hughes and Emma Findlay explain the purpose of the Surgical Care Observatory and why successful surgical innovation is about far more than the tech itself. They discuss system readiness, and how sociotechnical frameworks can help the NHS implement new technologies safely, effectively, and sustainably.This episode was recorded on 24th November 2025. If you would like to get in touch regarding this episode, please contact research.lubs@leeds.ac.uk. A transcript of this episode is available. Visit the project webpage.This project is funded by the National Institute for Health and Care Research (NIHR).About the speakers: Dr Helen Hughes is an Associate Professor at Leeds University Business School and Director of the Behaviour Lab. Helen in an interdisciplinary researcher, whose research spans aerospace to healthcare sectors. Helen is currently an Associate Editor at Ergonomics journal, and a Co-Investigator within the NIHR-funded Surgical Health-Tech Research Centre, where she leads the ‘Surgical Observatory' workstream. Emma Findlay is a Research Officer at Leeds University Business School, working in the Surgical Care Observatory theme of the HealthTech Research Centre in Accelerated Surgical Care. Her research explores the underpinning psychology of complex systems; including medtech implementation, surgical sustainability and multiteam system functioning. Articles mentioned in this episode and related reading:“Organisational psychologists – essential to saving the NHS”, The Psychologist, 31 October 2025, Helen Hughes and Emma Findlay “The Principles of Sociotechnical Design”, Human Relations, Albert Cherns, 1976 “Sociotechnical principles for system design”, Applied Ergonomics, Chris Clegg, 2000“Leveraging socio-technical systems to tackle grand challenges: Reflections on human-robot teams, hybrid workplaces, med-tech, and digital transformation”, Ergonomics, Matthew Davis, Helen Hughes, Mark Robinson, Jeffery Scales, Shankar Sankaran, Dikai Liu, Emma Findlay and Emma Gritt, 2025

While the companionship of pets has been studied in the context of cardiovascular health, their role in protecting brain health is less studied. Join us to investigate how an everyday dog walk may boost brain health through dementia risk-reduction factors including physical activity, well-being, social connection, and cognitive engagement. Co-host Jay Ingram – and author of The Science of Pets – joins psychologist and aging-brain expert Dr. Theone Paterson (University of Victoria) to explore how pets can help you defy dementia, while Dr. Lillian Hung (University of British Columbia; Vancouver Coastal Health Research Institute) discusses innovations in dementia care technology, including robotic pets. Tune in at defydementia.org, or anywhere you get your podcasts. Learn more about our guests: Dr. Lillian Hung is an Associate Professor at the University of British Columbia School of Nursing and Clinician Scientist at Vancouver Coastal Health Research Institute, and the founder of the IDEA Lab. She leads a dynamic team of academics and patient and family partners dedicated to advancing dementia and aging research. Through co-designed projects and collaborative research, the IDEA Lab fosters innovation, emphasizing shared benefits and meaningful engagement to improve care and support for those affected by dementia. She focuses on patient-oriented research and innovative care for people living with dementia and their caregivers.  Dr. Theone Paterson is an Associate Professor in the Department of Psychology at the University of Victoria; an Affiliated Investigator at the Vancouver Coastal Health Research Institute, Affiliated Researcher at Fraser Health; and a Registered Psychologist with practice in Neuropsychology. She is the Past Chair of the Clinical Neuropsychology Section of the Canadian Psychological Association; and is currently a Co-Investigator and Local Site Principal Investigator for the UVic Data Collection Site of the Canadian Longitudinal Study on Aging. Her research interests include improving understanding of the interplay between cognition and psychosocial functioning and predicting real-world cognitive health outcomes as we age. 

In this episode, we step inside the NHS to explore how the Generation Study is brought to life - from posters in waiting rooms to midwife training. We follow the journey of parents joining the study at the very start of their baby's life, and hear from those making it happen on the ground.  Our guests reflect on the teamwork between families and hospitals, the importance of informed consent, and the powerful insights this study could unlock for the future of care and research.  Our host Jenna Cusworth-Bolger, Senior Service Designer at Genomics England, is joined by:  Tracie Miles, Associate Director of Nursing and Midwifery at the South West Genomic Medicine Service Alliance, and Co-Investigator for the Generation Study at St Michael's Hospital in Bristol Rachel Peck, parent participant in the Generation Study and mum to Amber If you enjoyed today's conversation, please like and share wherever you listen to your podcasts.  For more on the Generation Study, explore:  Podcast: How has design research shaped the Generation Study  Podcast: What can we learn from the Generation Study  Podcast: What do parents want to know about the Generation Study  Blog: Genomics 101 - What is the Generation Study  Generation Study official website   “I think from a parent's point of view I guess that's the hardest thing to consent for, in terms of you having to make a decision on behalf of your unborn child. But I think why we thought that was worthwhile was that could potentially benefit Amber personally herself, or if not, there's a potential it could benefit other children.” You can download the transcript, or read it below. Jenna: Hi, and welcome to Behind the Genes.   Rachel: I think if whole genome sequencing can help families get answers earlier, then from a parent perspective I think anything that reduces a long and potentially stressful journey to a diagnosis is really valuable. If a disease is picked up earlier and treatment can start sooner, then that could make a real difference to a child or even Amber's health and development. Jenna: My name is Jenna Cusworth-Bolger and today I have the great pleasure to be your host. I'm a senior service designer at Genomics England specifically working with the hospitals involved in delivering the Generation Study. In March 2023 we started with our very first hospital, St. Michael's in Bristol. I am today joined by Tracie Miles who I had the utter pleasure of working closely with when they were setting up. And we also have Rachel Peck, one of the mums who joined the study in Bristol. Regular listeners to this podcast may already be familiar with the Generation Study but for those who are not, the Generation Study is running in England and aims to sequence the genomes of 100,000 newborn babies from a cord blood sample taken at birth. The families consented to take part will have their babies screened for over 200 rare genetic conditions most of which are not normally tested for at birth. We expect only 1% of these babies to receive a condition suspected result, but for those 1,000 families that result could be utterly life changing as it could mean early treatment or support for that condition. Would you like to introduce yourselves and tell us what it means to you to have been that first hospital open in this landmark study. Tracie, I'll come to you first.  Tracie: Hi Jenna, lovely to be with you all this morning. And for those who are listening it is early in the morning, we get up early in the morning because we never know when these babies are going to be born on the Generation Study and we have to be ready for them. So, my name is Tracie, I am the Co-Investigator with the wonderful Andrew Mumford, and we work together with a huge team bringing this study to life in Bristol. I am also the Associate Director of Nursing and Midwifery at the South West Genomic Medicine Service Alliance. Jenna: Thanks Tracie. We're also joined today by Rachel. Would you like to introduce yourself and your baby, and tell me when you found out about the Generation Study?  Rachel: Hi, thank you for inviting me. My name's Rachel, I'm based in Bristol. My baby is Amber; she was born four months ago in St. Michael's hospital in Bristol. I first heard about the Generation Study when I was going to one of my antenatal appointments and saw some of the posters in the waiting room. Amber is napping at the moment, so hopefully she'll stay asleep for long enough for the recording. Jenna: Well done, that's the perfect mum skill to get a baby to nap whilst you're busy doing something online. So, Rachel, you said you heard about the study from a poster. When you first saw that poster, what were your initial thoughts? Rachel: I thought it was really interesting, I haven't come across anything like that before and I thought the ability to screen my unborn baby at the time's whole genome sounded really appealing.  Jenna: Fantastic. So, what happened after the poster?  Rachel: If I remember correctly, I scanned the QR code on the poster which took me to the website. I filled out a few simple questions online and then I was contacted by one of the research team where I arranged a formal consent conversation. That was done by Zoom I think in the evening because I've already got a toddler at home so post bedtime works best for me. So, we had about a forty-minute conversation on the phone where I could ask all the questions that I needed to ask and if I was happy which I was. I then gave my consent and then I believe my maternity records were kind of highlighted to say that I signed up for the Generation Study and that when my baby was born then a sample was going to be taken, and I would be given the results in due course. Jenna: And did all that go smoothly, that you're aware of? Rachel: Yeah, as far as I'm aware. It was genuinely really simple to do. After that initial consultation where I signed the consent form there wasn't any follow-up appointments so the next thing I knew, I think it was just chance, but one of the research nurses actually came down to see me on the day which was really nice. Just to say, ‘Oh, just to let you know that the team are aware.' And then, other than that, the next thing I knew was getting the results through by post. Jenna: Sure. So, behind the scenes your baby's blood was collected from the umbilical cord, that would have been registered, packaged, sent off and went on a whole journey for you to ultimately get your result. It all sounds very simple, but I think we're going to dig into a lot of the mechanisms that kind of went behind the scenes to make something that seems simple come to life. Tracie, we met in the summer of 2023 I believe. I came to St. Michaels with a suitcase full of our materials which we had started to bring to life, including that poster. We've sat together and we were trying to figure out exactly how this was going to come to life in our very first hospital and how, what Rachel described, was actually going to become real. Tracie, can you tell me what you remember about those conversations and the thinking that you did as a team ahead of getting that green light to go ahead and start recruiting?  Tracie: Listeners, just to let you know that Rachel hasn't been primed to say that it was a seamless journey from delivery to getting results. I'm delighted to hear that it was. And I think the reason that we've achieved that in Bristol and across England now with the other teams that Jenna and the team have helped roll out, is teamwork. And part of our team is our mum, in this case Rachel. If you hear me or Jenna describing our mums as "Mia", that's the name, the significant name or the identifier we give for our participant. So, yeah, Jenna, I think the thing was it was about those first conversations. It was about teamwork and who shall we involve? We involved everybody didn't we, Jenna? So, I know that the team, by the time they came to us they'd already been planning for two years. So, in fact what came to us in Bristol was a wealth of work and information, and two years of behind the scenes of the team working. We involved every midwife. Now a midwife is a cover all term.  We involve community midwives, research midwives, antenatal midwives, post-natal midwives. They all do different things for the mum pathway. Not forgetting dad as well, he is involved in all of this and Rachel I'm sure will testify later to the fact that when she was offered the consent, her partner was offered to come along too. UHBW, that's United Hospital Bristol and Western, that our maternity hospital as part of, have got a fantastic R&D department and they were on straightaway with the rule book checking that we knew what we were doing. So, for those of you that aren't in the medical world, that's making sure we've got the right governance, that we're doing things by the rule book. Andrew went out and spoke to lots of different clinicians that would be involved in the pathway after the results were back, for those babies where we found a condition suspected. So, essentially Jenna, I think the list that was fairly long, grew longer and longer. Jenna: I think that was something that I was really struck by when I came back and visited you repeatedly after that. You were particularly good at getting some of those staff members that you might not even think about involved in the study, like the receptionist on your sonography department who you had recruited to make sure that they gave out the leaflet and the participant information sheet to all the mums coming in for their twenty-week scans etc. All that thinking was really valuable and something that I've passed on and taken out on my trips to other hospitals along the way. We heard from Rachel that she heard about this study from the poster. Now that you've been going for just over a year, what are all the different ways that people hear about the study, is it just the poster? Tracie: No, it's not just the poster. So, essentially when we first opened, we had lots of material. We had banners, we had posters. A short leaflet that you might often pick up at the GP, a little one that you can unfold into three pieces, and then a bigger patient information leaflet which actually described the whole study and also signposted the mums and dads to go and have a look on the website to hear more about it. What we did was we literally walked the mum's journey as she came into the hospital through antenatal and placed those posters and leaflets in the places where we knew she would see them. Now we had to be very careful about that as well because we couldn't just distribute them everywhere, we wanted to make sure that mum was getting sight of them, or mum and dad if they were coming together, at a place where their pregnancy was in hopefully, a safe position. So, that's around about 20 weeks onwards.   We didn't want to be giving that information out in the early days of pregnancy when actually mum and dad are getting flooded with lots of information, but we wanted them to feel secure in their pregnancy and for us to feel clinically secure. That worked really well and really effectively, but there's nothing like people pairing. So, in fact getting our ultra sonographers. So, for those of you that have been through pregnancy will remember at around about twenty weeks you have a scan, it's often called a dating scan or an anomaly scan, and we would get our receptionist to physically hand out a leaflet then. What we have evolved over the last year working with the team from Genomics England to make sure that we keep the wording right so that we can share with all the other sites across England, because it's good to have consistency. And also, as this evolves if this becomes standard of care, if this proves that actually this is useful for future-proofing for all of us in the public, if this study becomes something in real clinical terms, we've actually started sending out what we call, a signposting email. So, this is an email that goes to all of our prospective parents at 20 weeks plus, once we've checked that the pregnancy is safe and healthy. That has absolutely paid dividend and actually plays into the NHS future promise of analogue to digital to using those quick smart ways of working to reach our families. So, that has created a huge influx of recruits for us, Jenna.  Jenna: That's really interesting. We've sort of observed that same sort of thing. As we go through the hospitals now there's kind of three main ways that people are finding out the study. We call it like the passive way. So, that's what Rachel did which is the posters, the banners, but that doesn't work for everyone. In hospitals poster blindness is real. And also, you're coming for your twenty-week scan, you've got other things on your mind. You're not really looking around wanting to pick up leaflets and things and obviously we've also got to think about our non-English speakers. Or even an English speaker who sees the poster, but their literacy isn't very high, or their health literacy isn't very high. So, reading a message that says something about genomics and testing, it can be quite overwhelming for people and not something that they would respond to.  So, then we're signposting as our other kind of keyway and that's trying to get exactly what Tracie described, all the different staff involved. Who could be physically putting this leaflet in somebody's hand? Who could be mentioning it albeit briefly, just, you know, this is something you might like to consider. Rachel, I want to ask you what Tracie was describing there about the message kind of being better to be given later in pregnancy or after that 20-week scan point, because of all that information overload you get earlier in your pregnancy. Does that resonate with you?  Rachel: Yeah, I think that sounds about right. For lots of people when there's so much uncertainty in early pregnancy and I think some people are quite almost superstitious and don't want to sign up for things that potentially might not happen. So, I think from a personal perspective and from other friends who haven't been quite as fortunate, I think actually waiting until a little bit later when you've got a little bit more headspace and mental capacity for that sounds about right. I think there's too many things early on. It sounds like you're aiming at the right spot. Jenna: Absolutely. I think one of the other interesting aspects of all of this is the fact that Amber's cord blood was taken on the day that Amber was born, and I'm interested to understand a little bit about how that baton was passed from the moment that you consented, Rachel, to make sure that that sample was taken. I know it sounds like Rachel; you were in hospital at a point that the staff were there so they actually popped down to your bedside to see you but that doesn't always happen. Our teams don't work 24/7 and babies do get born at 2:00 a.m. over a bank holiday weekend. But Tracie, how do you make sure that that kind of message is passed through at St. Michaels, and what's worked well and what have the challenges been?  Tracie: So, a bit like how did we get the message through, is there one way? And the answer is no. There are posters, there are emails, etc. What we do do is first and foremost we encourage our mum, like Rachel here, and the dad, it might be two mums coming in together, to advocate for themselves. To say, ‘I'm on the Generation Study.' We don't expect that to be the only signal however because if a mum is coming in in full labour having done that a couple of times myself, I might forget. Now Genomics England have made some great bag tags, some stickers, all sorts of different visual identifiers that some hospitals around England are using, some aren't. We in fact actually don't get our mums to carry them, that may change. There are lots of different ways of doing it and every hospital maternity unit will find their fit. So, visual clues that mum and dad, or mum and mum, advocating for themselves as they come in, but also making sure that we have spoken with the delivery suite midwives and the theatre midwives.   Because in our hospital, which it seems to be the same sort of ratio around the country, sometimes up to about 40% of deliveries are done in theatre. So, we need to make sure we talk to our theatre staff and the people there as much as our central delivery or labour ward, for listeners who aren't familiar with the terms. So, we make sure that we went and walked the floor in the delivery labour ward and theatre on a regular basis. So, the task for us was to make sure that our midwives, all 200 of them know that if a mum is in the Generation Study and coming in for delivery, that they know that she's on the study. So, ways we do that is research midwives are an absolute ally, they do walk the floor. They do pop down to delivery suite and they do alert the team that there is a potential that a mum might be coming in that week with a planned Caesarean section, that's one easy. That actually can be an email. But we still do that by word of mouth, or they have a big board up in the delivery suite, which I gather is quite often the way across a lot of the country. Also, really, really key and this once again fits with our NHS plans, analogue to digital. The majority of our sites now are taking on electronic records. So, we put a key flag on the electronic record to say that this mum is on a research study. Staff are used to that because it's not the only research study that is happening. Now it doesn't have to just be an electronic note, it can be done on the retro paper notes as well. So, for those of you that have got paper notes or if we've got mums who are holding paper notes, fear not, there is an area on the notes where we can put that too. So, it's basically anywhere where we know the delivery midwife has sight of the babies' notes we will put a sticker, we will say something. So, it's one size doesn't fit all. Jenna: Yeah, what you've described there is just so lovely and so true about it's got to be belt and braces. The research team, the study team and the hospital might be a small number of people working Monday to Friday. Your people you completely rely on are those huge numbers of delivery midwives that need to have that message transmitted to them potentially over a 20 week timespan from the time the consent has happened to that day that that baby is born. So, what was really key as my role as service designer was going to the sites. I'm still doing this to this day, onboarding new sites all the time. We go and we speak to the sites, help them envisage how they might deliver this, how it's actually going to work. What's the nitty-gritty of all that mechanism that's going to happen but making sure that what they really understand is, what's the outcome? What do we want to happen? We want as many babies as possible to have those cord bloods taken and not missed. How you actually send that message whether it's through a paper note, a sticker on a paper note, giving a pack to the family to bring in so they've got something physical to hand over to their delivery midwife as a physical memento. Magnets that are put on the handover boards, or any or all of these things, in lots of ways the hospitals that have still got paper notes actually find it easier because that can staple a bag with the bottle that we use for our cord blood samples and this mum is part of the Generation Study to the front of the notes. It's more obvious than it would be as a digital flag. Tracie: I totally agree with that, it's all about that visual cue that we were talking about earlier. We actually fund a midwifery support worker, her name's Lauren. Hello Lauren, if you're listening. And what Lauren does is actually she makes sure that in all the rooms where women deliver that there are little set bags with all the equipment needed to take that cord blood. She also came up with a brilliant idea and again, a visual clue and Genomics England help us to design it, a poster. We would put on the outside of the door of mum and dad when they said they were on the study. So, if you've got a changeover of midwives then those midwives know that they're going into a room to support and deliver a mum that's got a baby on the study. Jenna: And I think that's something that's really key is what you said there about Lauren and her bright idea to create that poster and things like that, and that's been really key to how we've worked from Genomics England as a kind of service design kind of wrapper if you like around all of these hospitals. I have taken on the role of chief pollinator, so I've flown from hospital to hospital taking all the best ideas. So, Lauren's idea of the poster, I came along and I took a photograph of that poster. That poster is in a slide and that slide gets shown when I go and do onboarding and training sessions with future hospitals. Bristol were really key because as our first site and as the first early days check in we did, the photographs I took at your hospital at Birmingham Women's and at the Rosie in Cambridge which were the first three hospitals, you still to this day make up a large percentage of what we show because you were the first to have all those great ideas and we share those out. But we don't go round all the other hospitals, and we have found new ideas all the time and they are put together in our service design manual which is all available for all the sites. Something that St. Michael's can refer back to to see what new things they could be thinking about. But basically, raising up the best and allowing hospitals to borrow from each other. Before we just move on from how it all works, I just want to ask Rachel, did you notice any of that or were you very busy having a baby? And did you remember to kind of advocate to yourself and mention the study? Rachel: I did remember to advocate for myself, also it was one of the jobs that I allocated to my husband as well as a, well, if I forget which is likely, can you make sure that you mention to them. I had a caesarean section. For other people who have had caesarean sections, there's quite a lot of waiting round time. So, when we were in the theatre getting ready, having a chat with the anaesthetist it was a nice opportunity to be able to take my mind off the impending surgical procedure and just mention about the Generation Study. But incidentally, they knew about it anyway. I think I remember seeing some kind of sticker or maybe the blood tubes or something on my theatre records. But see them taking the sample, I wasn't aware, I had other things on my mind at that point. Jenna: Absolutely. You were cuddling Amber for the first time probably. One of the things that you touched on Tracie, was you had to go round all of your delivery suite midwives and make sure they all knew how much blood to take, what tube to put it in. The fact that they had to invert it 10 times, put it in a particular fridge so that you knew where to find it. All of those are really important training messages that you had to pass on. But for you to be able to pass them on, we had to train you in the first place. So, my memory was that we came down to you one cold December day and spent a whole day with you down at St. Michaels trying our best to train you as seamlessly as we could. My memory of that day is it wasn't terribly slick because it was our first and we're always learning. I'd like to think we've got it a lot more slick now, but what do you remember about that day? And just in general kind of learning what you needed to do on the study and what kind of worked well for you, and what worked less well? Tracie: I do remember that day, it was very cold. I think what's changed Jenna is on that December day the whole team felt that they were having to take on the whole of the journey. They now as the work has developed, realise and learn the part of the journey that they need to be involved in and don't have to be concerned about the rest of the journey. Jenna: I learnt an awful lot and I think it's really true that it's really important that people who are taking the samples, they just need to know their role. But they do need to know a little bit about what the study is, why it's worthwhile, why this mum has signed up and what value it's going to bring to that family. I think the other thing that we learnt when we came to your training as well was in the same way that we went a bit too deep for some people in their role, we didn't go deep enough for your team that were actually going to be doing these consent conversations. At that, at end of that training day, you still felt trepidatious about doing those conversations and so we really took that on board and then developed our informed choice cards which are like scenario cards that allow teams to kind of practice, rehearse and think through how they're going to answer those common questions. And we've taken those into a session that allows people who are just doing the consent conversation to go even deeper, so we do that online in a webinar now which we run monthly and that allows any new members of staff to go that little bit deeper in terms of what is this consent conversation? What is it that I need to get people to understand and be fully informed about before they come into this study? A key objective of the Generation Study which after all is a research study, is to understand if the NHS and families would benefit if screening for conditions via whole genome sequencing was something that became part of NHS standard care. Rachel, can I ask you as a mum, is that something that you've reflected on at all and how would you feel about it?  Rachel: Yeah, I've thought about quite a bit. I think if whole genome sequencing can help families get answers earlier then from a parent perspective, I think anything that reduces a long and potentially stressful journey to a diagnosis is really valuable. If a disease is picked up earlier and treatment can start sooner, then that could make a real difference to a child or even Amber's health and development. So, I think that would be potentially very advantageous. I guess in a resource limited NHS that we have, there are, you know, clear challenges in rolling out whole genome sequencing for everyone. But I'm guessing that the Generation Study will provide the evidence to help understand if this is feasible or worthwhile. And clearly the Generation Study needs to show that the screening of these 200 or so conditions is as good as the existing screening that already exists. From a parent perspective, if it's shown to be equally as good at doing that, plus all these other disorders then it seems like a win-win.  I think for me the main advantage and the main reason why I was keen to enter for Amber was if she were at risk of getting one of these rare disorders then there's an advantage to picking that up earlier for her. Because I'm aware that lots of people if they have a rare disorder, it can take a long time to get to that diagnosis and that can be really stressful for you as the parent but also for the child. Anything I think to minimise their suffering is worthwhile. So, it sounds fantastic, if it works. Jenna: Absolutely and I think that's what's really nice about being involved in something like this is that the study itself is set out to find out those things. It's not set out to find out how we could do whole genome sequencing in the NHS, it's whether we should. As part of the study, you also consented to have Amber's data go through into the National Genomic Research Library which leads us to one of the secondary objectives of the Generation Study which is to understand the implications of keeping a baby's genomic data over their childhood, or even over their lifetime. Amber will be contacted when she is 16 by Genomics England to find out whether she herself is happy for her data to be kept. But keeping that data for that length of time offers up opportunities for further screening for other conditions later in Amber's life. Or using that data with your consent of course, to do further research into genes and health. And so over the next few years you may be contacted by Genomics England to invite you to take part in future studies. And, I was just wondering about how much you have been told about the potential for that and again, how you feel about that kind of aspect of being part of this study. Rachel: Yeah, that was definitely discussed quite a lot in the consent conversation that I had with Siobhan, and we were told that Amber's data would be stored long term and that there might be future opportunities for the team to kind of get in touch or do additional testing. And I think from a parent's point of view I guess that's the hardest thing to consent for in terms of you having to make a decision on behalf of your unborn child. But I think why we thought that was worthwhile was that could potentially benefit Amber personally herself, or if not, there's a potential it could benefit other children. So, I think that whole kind of for the greater good, that kind of prevailed. And I think the other, not concern as it were, but other thing we wanted to discuss with that consent was the security of that data. And certainly, when I was discussing it with my husband that was his kind of main point to kind of clarify, if the data is being stored long term and if that was safe. And in terms of the safety, thinking about could future employers or can insurance companies, you know, get hold of that data? As a parent, the last thing you want to do is accidentally prevent your daughter from getting a job that she wants to get. But it was all explained that that wouldn't happen, but I think that was something that was us for us personally important to clarify. Jenna: I think that's really where that depth of the consent conversation is so key and why we do that sort of additional training to allow staff who may be very used to doing research and doing research consent, but never before have done a genomic consent where it's about keeping genomic data and the implications of keeping it for that really long time. What else do you remember about that consent conversation, Rachel? Is there anything else that kind of stands out that you had to sort of really dig into with Siobhan on that day?  Rachel: I'm just trying to think back because it was a little while ago. The main kind of points that I want to discuss was the security of the data and then what would happen if for whatever reason the umbilical cord blood sample wasn't taken and if that meant that we could still be part of the study or not. It was explained that yes, there is a way, they would do an initial heel prick blood sample. But that was reassuring to know that if for whatever reason if there was some kind of emergency and it didn't happen the way we wanted. So, I think that was the other kind of practical thing that was discussed.  Jenna: It sounds like Siobhan sort of had by that point all of the answers at her fingertips, but that kind of links back I guess to how important it is for all the training and all of the materials, because quite a lot of the answers to those questions are in the participant information sheet. Quite a few of them are covered in the participant video which is a sort of a four-minute-long video, it's meant to make the understanding a little bit more accessible. But it's not relying on one route of information, it's the conversation and that face to face you have with someone. It's the written information and it's those videos and other materials. So, we need to go as far as we can to kind of get the word out. One of the limitations that we had, certainly back in the day when we just had St. Michael's and a couple of other hospitals on board was that trying to get the word out about the study widely was also going to disappoint quite a lot of people who weren't able to take part because their hospital wasn't in it. We've talked a lot about this consent conversation, and I think something that's really important, underpinning for the whole study is the ethics that's been involved and all the work that's been done around that area. As the study is free and optional and taking part involves a commitment from families to have babies' data held for at least 16 years, the consent conversation and getting that right is so vital. We touched upon this in a previous episode with my colleague Mathilde Leblond where we talked about all the design research that our team did in the build up to launching this study, so that we could really deeply understand what families wanted and needed as part of their experience. So, Tracie, we've heard from Rachel the things that she was concerned around, but what were your reflections as a team in St. Michaels around the ethical aspects of the study? And what has been particularly tough about that in relation to you guys in Bristol? Tracie: I would say informed consent is something that we all take as healthcare professionals, and we all hold dearly the governance. So, I was mentioning earlier that actually consent may not be a one-off situation. So, for example, Rachel had forty minutes with Siobhan. That was the conversation that she had where Rachel felt that she was enabled and informed enough to take consent, and Siobhan listening to her having that conversation with Rachel felt that that was appropriate at the time. So, consent was achieved between the two of them. Now, that wasn't the only part of Rachel's consent is Rachel was telling us there's the patient information leaflet that she read, so that's also part of the informed consent. And we have to be sure that our mums and the other parent of the baby have read that information. And one of the things that I was very worried especially about at the beginning was it's a superb information leaflet, it's quite long, it needs to be. It signposts the parents of the unborn baby to a website which is fantastic. Do they all look at it? Not always. Would I? Probably not. So, there's no criticism of the parents here. So, one of the things that I was really concerned about from the genomics perspective of this and the data protection because this is not a one-off, this is a longitudinal study. Amber when she's 16 years old will decide whether or not she wants to continue, so it's not a one-off moment that her lovely mum and dad have consented her for. There's a lot that's been consented for. All great and all appropriate and all future-proofing for future Ambers. But my concern was actually, are we getting that information across to all the mums and dads as they sign up? So, it was really important that when we were training our midwives and our genomic practitioners, those that were consenting, to make sure that they were really cognisant of the enormity of the wealth of science we were signing our parents and their babies' futures up to. Jenna: Indeed, and very well said and I think you touched on something that is really close to our hearts as well that we've thought a lot about but still continue to do work to get right, which is the patient information leaflet if you have the health literacy and written language literacy to be able to sit and read a 16-page document, great, but not everybody does. As I've gone place to place and hospital to hospital, I'm always struck by the different communities that surround different hospitals and the different challenges that they might have. So, if you compare somewhere like Royal London which is in the heart of Whitechapel, I think around 40% of their birthing parents there are first generation Bengali women who have little to no English. Also, whose health literacy is quite low as well. So, engaging them takes a very different approach to an approach you might take elsewhere. So, it's definitely not a one size fits all. Tracie, how have you adapted some of your approaches to your local communities in Bristol? Tracie: So, we have a fairly diverse population, not as diverse as the Whitechapel example that you gave, but in fact we were aware, a bit like the team in London that we have a population of Somali potential birthing parents. What we've done is we've worked with community leaders and elders from the Somali population to develop a day, or it might be a couple of mornings, for us to talk about and workshop to explain about the study. So, we have all of the information. We have the translations that have been done by Genomics England. And hat we are doing is we are working with the community elders for them to tell us the right fit. Should it be a whole day? Probably not. Should it be a coffee morning or a tea morning? Probably. Should it be where we get a guest speaker in? That was their idea. What is the key condition suspected, one of those 200 conditions that the study is looking at that is prevalent in that community? Let's ask the community elders what they think, and we'll do what we're told. So, it's been fabulous actually doing that. Jenna: It's really, really great to hear about that. I think we've got little pockets of work like that popping up all over the country now which is really exciting to start seeing. I think at first, we were very much about getting the study up running and out there. And now we're starting to make sure we get that reach and we get that equity, and the opportunity for all pregnant people to decide whether this is right or wrong for their family. It's about informed choice and you can't make an informed choice whether that's an informed yes or an informed no if you don't have the information. We are proud that we go further than most research studies in terms of our accessibility, in terms of translations and we know that not English speaking is not the only barrier to access, there's lots of cultural barriers as well. But with the translated materials we support 10 languages as far as our professionally translated participant information leaflet. I was also really pleased when I found out at first that our website team had built the website in such a way that it worked not only with screen readers. So, somebody with a visual impairment could ‘read', in inverted commas, the website but that also it translates via Google into the 160 languages that Google support, which we know Google translations aren't perfect but they're better than nothing. And going back to what Tracie sort of said, the website doesn't have to do everything, it's about a conversation at the end of the day. It's a consent conversation that can be supported by a professional interpreter but it's about getting that initial message out there so they even get as far as having that conversation with an interpreter. We heard from Rachel around her reflections for the future, Tracie, about the study potentially becoming NHS standard care and about that potential of us having Amber and 99,999 other babies' data in the National Genomic Research Library and the potential that gives us for further research. Or for potentially re-screening those children as they grow up. When you look to the future and think about the Generation Study and what it might pave the way for, what are your hopes or perhaps fears? Tracie: So, my belief working in the genomics field is genomics is everybody's business. So, it's the 3 of us talking today, we're all very keen about genomics but there is a fear around genomics. Actually, I feel that this landmark study is absolutely fantastic. It makes genomics everybody's business. And it actually helps the whole healthcare community looking after these parents and the unborn babies as they go through the journey learn about the positivity of genomics. I think this landmark study is an absolutely win-win. It speaks to the whole family. Jenna: Thank you, Tracie. I'm also particularly excited about what the future could hold. I think as the service designer that's been working so closely with the hospitals, I'm really excited around what we've learned through this study in terms of reaching families and getting genomic information and options out to them. As you say, it is everybody. I continue to enjoy meeting new hospitals and seeing their kind of innovative take on that and kind of pollinating that back to other trusts so that we can reach as many families as possible and get that equity of access for everybody. I'm also particularly excited that we're moving into a phase where we're going to be learning more from the parents themselves that are taking part.  So, I think we'll wrap up there. Thank you to our guests Rachel, Tracie for joining me today as we discuss the rollout and impact of the Generation Study at St. Michael's Hospital in Bristol. If you'd like to hear more about this, please subscribe to Behind the Genes on your favourite podcast app. Thank you for listening. I've been your host Jenna Cusworth-Bolger. This podcast was edited by Bill Griffin at Ventoux Digital and produced by Deanna Barac.

What were the top musical hits of Shakespeare's England? What lyrics were stuck in people's heads? What stories did they sing on repeat? The 100 Ballads project is a deep dive into the hits of early modern England—a kind of 17th-century Billboard Hot 100. Drawing from thousands of surviving printed ballads, researchers Angela McShane and Christopher Marsh have ranked the most popular songs of the period. These broadsides—cheaply printed sheets sold for a penny—offer surprising insight into the period's interests, humor, and even news headlines. McShane and Marsh discuss what these ballads tell us about moral norms, sensationalism, and everyday life. Some are instructive, some are bawdy, and some are unexpectedly feminist. This episode brings to life the soundscape of Shakespeare's world with clips from newly recorded versions of the most popular ballads and a look at how the team developed their ranking system. >> Explore the project and hear the songs yourself at www.100ballads.org Christopher Marsh is Professor of Cultural History at Queen's University, Belfast. He has published extensively on various aspects of society and culture in sixteenth- and seventeenth-century England. His most relevant book in relation to the 100 Ballads project is Music and society in early modern England (Cambridge, 2010). This is an overview of music-making in the 16th and 17th centuries, and it includes chapters on musicians, dancing, bell-ringing, psalm-singing and, of course, ballads. Angela McShane is an Honorary Reader in History at the University of Warwick. She is a social and cultural historian, researching the political world of the broadside ballad and the political and material histories of intoxicants and the everyday. She has published widely on political balladry, including numerous book chapters, and journal articles in Past and Present, Renaissance Studies, Journal of British Studies, Journal of Early Modern History, Popular Music Journal and Media History. She is also the author of a reference work, Political Broadside Ballads in Seventeenth Century England: A Critical Bibliography (2011). A monograph on the broadside ballad trade and its politics in seventeenth-century Britain is forthcoming with Boydell and Brewer. She is also a Co-Investigator for a related website and book project: “Our Subversive Voice: The history and politics of protest music 1600-2020.” From the Shakespeare Unlimited podcast. Published May 6, 2025. © Folger Shakespeare Library. All rights reserved. This episode was produced by Matt Frassica. Garland Scott is the executive producer. It was edited by Gail Kern Paster. We had help with web production from Paola García Acuña. Leonor Fernandez edits our transcripts. Final mixing services are provided by Clean Cuts at Three Seas, Inc.

Hear from Prof. Aled Jones, Director of the Global Sustainability Institute at Anglia Ruskin University, as we dive into the role of models in shaping policy, and particularly their weaknesses.  Models are not neutral – they reflect the assumptions, values, and agendas of those that create and use them. Using the energy system as an example, models can (and have been) used to protect the status quo. In part, this is because many of the models are based on the notions of ‘equilibrium' and so they simply can't cope with major structural changes, such as the current energy transition. But it can be difficult for policy makers to switch towards models that are arguably more suited to the job. So, what can we do to supplement the models? One very effective approach is to adopt a structured process of expert elicitation, where we use the insights of experts to uncover vulnerabilities and risks. To bring it to life, we explore how this has worked in the case of the food system. We discuss: The role that models play in shaping energy policy, and how they can lead us astray; How expert judgment and insight can help address model blind spots; and Finally, what are the key lessons for risk professionals? To find out more about the Sustainability and Climate Risk (SCR®) Certificate, follow this link: https://www.garp.org/scr For more information on climate risk, visit GARP's Global Sustainability and Climate Risk Resource Center: https://www.garp.org/sustainability-climate If you have any questions, thoughts, or feedback regarding this podcast series, we would love to hear from you at: climateriskpodcast@garp.com Links from today's discussion: Global Sustainability Institute homepage: https://www.aru.ac.uk/global-sustainability-institute-gsi Institute and Faculty of Actuaries, Planetary Solvency Report: https://actuaries.org.uk/news-and-media-releases/news-articles/2025/jan/16-jan-25-planetary-solvency-finding-our-balance-with-nature/ GARP Climate Risk Podcast with Erica Thompson: https://www.garp.org/podcast/the-power-and-pitfalls-of-models-in-climate-risk-management Speaker's Bio(s) Prof. Aled Jones, Director, Global Sustainability Institute, Anglia Ruskin University Aled's work in climate finance was recognised by California and he has received a key to the city of North Little Rock, USA. He is a Co-Investigator on the ESRC Centre for the Understanding of Sustainable Prosperity, the AHRC Debating Nature's Value network, the Economics of Energy Innovation and System Transition project and leads the BBSRC Backcasting to Achieve Food Resilience in the UK project. He was lead author on the seminal report on resource constraints to the Institute and Faculty of Actuaries in 2013, was made an Honorary Fellow in 2018 and currently chairs their Biodiversity Working Party.

The new public sector Probation Service was created in 2021 to unify the outsourced management of low- and medium-risk offenders with the public sector management of high-risk offenders.   While the initial transition went well, four years on probation still faces deep structural challenges – as do other public services. The government is committed to public service reform and a ‘mission-driven' approach, but it is not yet clear what this will look like.   So what can the government learn about improving public service reform from probation insourcing? What are the implications for Labour's strategic review of probation governance? And what comes next for the probation service?   To discuss these questions and more, we were joined by an expert panel including:   Professor Harry Annison, Co-Investigator of Rehabilitating Probation Research Project, and Professor of Criminal Justice at Southampton Law School Helen Berresford, Director of External Engagement at Nacro Sam Freedman, Senior Fellow at the Institute for Government Martin Jones CBE, HM Chief Inspector of Probation   The event was chaired by Cassia Rowland, Senior Researcher at the Institute for Government.   This event was kindly supported by Rehabilitating Probation. Learn more about your ad choices. Visit podcastchoices.com/adchoices

The new public sector Probation Service was created in 2021 to unify the outsourced management of low- and medium-risk offenders with the public sector management of high-risk offenders. While the initial transition went well, four years on probation still faces deep structural challenges – as do other public services. The government is committed to public service reform and a ‘mission-driven' approach, but it is not yet clear what this will look like. So what can the government learn about improving public service reform from probation insourcing? What are the implications for Labour's strategic review of probation governance? And what comes next for the probation service? To discuss these questions and more, we were joined by an expert panel including: Professor Harry Annison, Co-Investigator of Rehabilitating Probation Research Project, and Professor of Criminal Justice at Southampton Law School Helen Berresford, Director of External Engagement at Nacro Sam Freedman, Senior Fellow at the Institute for Government Martin Jones CBE, HM Chief Inspector of Probation The event was chaired by Cassia Rowland, Senior Researcher at the Institute for Government. This event was kindly supported by Rehabilitating Probation.

Send us a textIn this episode, Simon speaks with Dr Katharine Fortin about non-international armed conflicts, focussing on the intersections between IHL, international human rights law and armed non-State actors. Dr Katharine Fortin is a senior lecturer of public international law and human rights at Utrecht University's Netherlands Institute of Human Rights. She is the Editor in Chief of the Netherlands Quarterly of Human Rights and founder of the Armed Groups and International Law blog. Her book The Accountability of Armed Groups under Human Rights Law (OUP, 2017) won the Lieber Prize in 2018. She is Co-Investigator on the Beyond Compliance Consortium: Building Evidence on Promoting Restraint by Armed Actors. Katharine has a LLM and PhD from the Utrecht University. She is a qualified solicitor in the UK and previously worked at Norton Rose Fulbright, the Council of Churches of Sierra Leone, the ICC and the ICTY.Additional resources:Fortin, Katharine ‘Mapping Calamities: Capturing the Competing Legalities of Spaces under the Control of armed non State Actors without erasing everyday civilian life' (2023) 8(1) Social Science and Humanities OpenMatthew Bamber-Zryd, 'ICRC engagement with armed groups in 2024' Humanitarian Law & Policy Blog (31 October 2024)Katharine Fortin and Ezequiel Heffes (eds), Armed Groups and International Law: In the Shadowland of Legality and Illegality (Edward Elgar, 2023)Naz Modirzadeh, 'Cut These Words: Passion and International Law of War Scholarship' (2020) 61(1) Harvard International Law Journal 1.Zoe Pearson, 'Spaces of International Law' (2008) 17 Griffith Law Review 489.Helen Kinsella, The Image Before the Weapon: A Critical History of the Distinction between Combatant and Civilian (Cornell University Press, 2015)Kieran McIvoy, 'Beyond Legalism: Towards a Thicker Understanding of Transitional Justice' (2007) 34(4) Journal of Law and Society 411.Sally Engle Merry, The Seductions of Quantification: Measuring Human Rights, Gender Violence and Sex Trafficking (University of Chicago Press, 2016)Ana Arjona, Rebelocracy: Social Order in the Colombian Civil War (CUP, 2016)Zachariah Cherian Mampilly, Rebel Rulers: Insurgent

In this month's episode we interview Dr Laura Sangha (Associate Professor at the University of Exeter) about her research on angels and other supernatural beings. We also hear about her work as a Co-Investigator on the Leverhulme Project 'The Material Culture of Wills, England 1540-1790'. If you would like to volunteer with the project, you can find more information here.

In this podcast episode, Dr. Robert Whitfield, a board-certified plastic surgeon specializing in breast implant illness (BII), and Dr. Mithun Sinha, a PhD scientist, discuss the complexities of Breast Implant Illness. Dr. Whitfield shares his clinical experiences and emphasizes the importance of understanding the symptoms and experiences of women affected by Breast Implant Illness and Dr. Sinha provides scientific insights into the role of fatty acids, bacteria, and biofilm formation concerning breast implants, explaining how these factors contribute to symptoms like fatigue and brain fog. Be sure to tune in to hear more! Show Highlights: Role of Fatty Acids in Cell Structure (00:01:51) The importance of fatty acids in cellular stability and protection Interaction of Fatty Acids and Implants (00:03:20) Discussion on how fatty acids interact with breast implants and surrounding tissue Formation of 10 Home and Biofilms (00:05:20) Dr. Sinha describes how oleic acid transforms into 10 Home, linked to bacterial biofilms. Scar Capsule and Bacterial Colonization (00:06:40) Exploration of how the scar capsule provides a habitat for bacteria to form biofilms Historical Perspective on Surgical Techniques (00:12:40) Dr. Whitfield shares his experience with surgical techniques for patients with breast implant illness. Importance of Research on BII (00:13:41) Lack of attention to women suffering from BII and the need for better care Introduction to Oxaliplatin Home Research (00:14:54) Dr. Sinha introduces his new paper on oxaliplatin home and its link to inflammation Oxidation and Its Effects on the Body (00:16:04) Dr. Sinha explains how oxidation increases during stress and exercise, affecting health Potential Biomarkers for BII Symptoms (00:17:38) Discussion on identifying biomarkers to predict and assess symptoms in BII patients Characterizing Bacterial Contamination (00:19:54) Dr. Whitfield discusses the need to characterize bacterial contamination in patients with implants. Read Dr. Mithun Sinha's paper in The Aesthetic Surgery Journal. Oxylipins in Breast Implant–Associated Systemic Symptoms (https://academic.oup.com/asj/article/44/10/NP695/7690705) Bio. Mithun Sinha, PhD Dr. Sinha is an Assistant Professor in the Division of Plastic Surgery, Department of Surgery at the Indiana University School of Medicine. His laboratory specializes in the field of bacterial biofilm research. The investigations are focused on implant-associated complications due to biofilms and wound healing complications. These include breast implant-associated systemic immunological manifestations, dental implant-associated peri-implantitis, and orthopedic implant-associated osteomalacia. Studies also include wound healing studies exploring host-biofilm-mediated metabolites. His laboratory explores the development of implant-based biomaterials for their anti-biofilm properties. Over the years, he has actively collaborated with surgeons and chemical and material science engineers. He has been continually funded by NIH and currently have two active grants from NIH as PI (R01 and R21). He has also served/serving on 4 NIH grants as Co-Investigator. He has published 45 articles in peer-reviewed journals, with a Google Scholar citation of 2600+ and an h-index of 20. Seven of his publications have been cited 100+ times. A recent study from his lab on breast implant-associated immunological complications published in the Journal of Clinical Investigation (PMID: 38032740) has received editorial-type commentary from the peer community (PMID: 38299590). In addition to being a researcher, he has served as a reviewer for 15+ peer-reviewed journals. He also serves as Associate Editor for the journal RNA Biology and as an ad-hoc member of the NIH study section and Plastic Surgery Foundation (PSF) study panels. Connect with Dr. Whitfield: Podcast (https://podcasts.apple.com/gb/podcast/breast-implant-illness/id1678143554) Spotify (https://open.spotify.com/show/1SPDripbluZKYsC0rwrBdb?si=23ea2cd9f6734667) TikTok (https://www.tiktok.com/@drrobertwhitfield?_t=8oQyjO25X5i&_r=1) IG (https://www.instagram.com/breastimplantillnessexpert/) FB (https://www.facebook.com/DrRobertWhitfield) Linkedin (https://www.linkedin.com/in/dr-robert-whitfield-md-50775b10/) X.com (https://x.com/rjwhitfield?lang=en) Read this article (https://www.breastcancer.org/treatment/surgery/breast-reconstruction/types/implant-reconstruction/illness/breast-implant-illness) Shop Dr. Whitfield's Solutions (https://drrobssolutions.com) SHARP (https://www.harp.health) NVISN Labs (https://nvisnlabs.com/) Get access to Dr. Rob's Favorite Products below: Danger Coffee (https://dangercoffee.com/pages/mold-free-coffee?ref=ztvhyjg) - Use our link for mold-free coffee. JASPR Air Purifier (https://jaspr.co/)- Use code DRROB for the Jaspr Air Purifier. Echo Water (https://echowater.com/)- Get high-quality water with our code DRROB10. BallancerPro (https://ballancerpro.com) - Use code DRROBVIP for the world's leader in lymphatic drainage technology. Ultrahuman (https://www.ultrahuman.com/ring/buy/us/?affiliateCode=drwhitfield)- Use code WHITFIELD10 for the most accurate wearable.

In this podcast episode, Dr. Robert Whitfield, a board-certified plastic surgeon specializing in breast implant illness (BII), and Dr. Mithun Sinha, a PhD scientist, discuss the complexities of Breast Implant Illness. Dr. Whitfield shares his clinical experiences and emphasizes the importance of understanding the symptoms and experiences of women affected by Breast Implant Illness and Dr. Sinha provides scientific insights into the role of fatty acids, bacteria, and biofilm formation concerning breast implants, explaining how these factors contribute to symptoms like fatigue and brain fog. Be sure to tune in to hear more! Show Highlights: Role of Fatty Acids in Cell Structure (00:01:51) The importance of fatty acids in cellular stability and protection Interaction of Fatty Acids and Implants (00:03:20) Discussion on how fatty acids interact with breast implants and surrounding tissue Formation of 10 Home and Biofilms (00:05:20) Dr. Sinha describes how oleic acid transforms into 10 Home, linked to bacterial biofilms. Scar Capsule and Bacterial Colonization (00:06:40) Exploration of how the scar capsule provides a habitat for bacteria to form biofilms Historical Perspective on Surgical Techniques (00:12:40) Dr. Whitfield shares his experience with surgical techniques for patients with breast implant illness. Importance of Research on BII (00:13:41) Lack of attention to women suffering from BII and the need for better care Introduction to Oxaliplatin Home Research (00:14:54) Dr. Sinha introduces his new paper on oxaliplatin home and its link to inflammation Oxidation and Its Effects on the Body (00:16:04) Dr. Sinha explains how oxidation increases during stress and exercise, affecting health Potential Biomarkers for BII Symptoms (00:17:38) Discussion on identifying biomarkers to predict and assess symptoms in BII patients Characterizing Bacterial Contamination (00:19:54) Dr. Whitfield discusses the need to characterize bacterial contamination in patients with implants. Read Dr. Mithun Sinha's paper in The Aesthetic Surgery Journal. Oxylipins in Breast Implant–Associated Systemic Symptoms (https://academic.oup.com/asj/article/44/10/NP695/7690705) Bio. Mithun Sinha, PhD Dr. Sinha is an Assistant Professor in the Division of Plastic Surgery, Department of Surgery at the Indiana University School of Medicine. His laboratory specializes in the field of bacterial biofilm research. The investigations are focused on implant-associated complications due to biofilms and wound healing complications. These include breast implant-associated systemic immunological manifestations, dental implant-associated peri-implantitis, and orthopedic implant-associated osteomalacia. Studies also include wound healing studies exploring host-biofilm-mediated metabolites. His laboratory explores the development of implant-based biomaterials for their anti-biofilm properties. Over the years, he has actively collaborated with surgeons and chemical and material science engineers. He has been continually funded by NIH and currently have two active grants from NIH as PI (R01 and R21). He has also served/serving on 4 NIH grants as Co-Investigator. He has published 45 articles in peer-reviewed journals, with a Google Scholar citation of 2600+ and an h-index of 20. Seven of his publications have been cited 100+ times. A recent study from his lab on breast implant-associated immunological complications published in the Journal of Clinical Investigation (PMID: 38032740) has received editorial-type commentary from the peer community (PMID: 38299590). In addition to being a researcher, he has served as a reviewer for 15+ peer-reviewed journals. He also serves as Associate Editor for the journal RNA Biology and as an ad-hoc member of the NIH study section and Plastic Surgery Foundation (PSF) study panels. Connect with Dr. Whitfield: Podcast (https://podcasts.apple.com/gb/podcast/breast-implant-illness/id1678143554) Spotify (https://open.spotify.com/show/1SPDripbluZKYsC0rwrBdb?si=23ea2cd9f6734667) TikTok (https://www.tiktok.com/@drrobertwhitfield?_t=8oQyjO25X5i&_r=1) IG (https://www.instagram.com/breastimplantillnessexpert/) FB (https://www.facebook.com/DrRobertWhitfield) Linkedin (https://www.linkedin.com/in/dr-robert-whitfield-md-50775b10/) X.com (https://x.com/rjwhitfield?lang=en) Read this article (https://www.breastcancer.org/treatment/surgery/breast-reconstruction/types/implant-reconstruction/illness/breast-implant-illness) Shop Dr. Whitfield's Solutions (https://drrobssolutions.com) SHARP (https://www.harp.health) NVISN Labs (https://nvisnlabs.com/) Get access to Dr. Rob's Favorite Products below: Danger Coffee (https://dangercoffee.com/pages/mold-free-coffee?ref=ztvhyjg) - Use our link for mold-free coffee. JASPR Air Purifier (https://jaspr.co/)- Use code DRROB for the Jaspr Air Purifier. Echo Water (https://echowater.com/)- Get high-quality water with our code DRROB10. BallancerPro (https://ballancerpro.com) - Use code DRROBVIP for the world's leader in lymphatic drainage technology. Ultrahuman (https://www.ultrahuman.com/ring/buy/us/?affiliateCode=drwhitfield)- Use code WHITFIELD10 for the most accurate wearable.

Send us a Text Message.Professor Dr. Dan Blumberg, Ph.D. is the Vice-President for Regional and Industrial Development at Ben-Gurion University of the Negev ( BGU - https://www.blumberg.bgu.ac.il/ ), an elected Member of the International Academy of Astronautics, and Chair of the Israel Space Agency ( https://www.space.gov.il/en ), a position he was appointed to by the Ministry of Innovation, Science and Technology ( https://www.gov.il/en/departments/ministry_of_science_and_technology/govil-landing-page ) in 2022.Prior to these positions, Prof. Blumberg completed five years as Vice President and Dean for Research and Development at BGU and before that he fulfilled several positions including Deputy Vice President, Chairperson of the Department of Geography and Environmental Development and the founder of the Green Campus initiative at BGU which gained the University an international ranking of #18.Prof. Blumberg earned a Ph.D. from Arizona State University (1993) where he studied and worked in the Planetary Geology Group and focused on aeolian processes and microwave radar remote sensing to study arid zone environments and planetary geology.  He was a Co-Investigator on the SRL (Spaceborne Radar Laboratory) mission, SRTM (Spaceborne Radar Topography) mission and other space missions. Prof. Blumberg has been working for the past 20 years on analysis of multi-parameter remote sensing data including radar, hyperspectral, multi-spectral and ground penetrating radar data. He has also published numerous papers in the areas of target and anomaly detection and combined field studies with the use of remote sensing data.  He also led the development and successful launch on February 15, 2017 of a Nanosatellite, BGUsat. Prof. Blumberg has also been a key leader in the development of the cyber eco-system in Beer-Sheva ( https://www.blumberg.bgu.ac.il/_files/ugd/d86da1_7750b399fc5843af9763fd4e1ffe59af.pdf ), which brought 39 multi-national companies and 70 startups to the advanced technologies park in Beer-Sheva. Additional roles include as Director of the Homeland Security Institute ( https://in.bgu.ac.il/en/hsi/Pages/Board.aspx ) and Simon Family Chair in Remote Sensing at BGU.#DanBlumberg #RemoteSensing #Mars #Venus #BenGurionUniversityOfTheNegev #Astronautics #IsraelSpaceAgency #NASA #Geology #Geography #BaruchBlumberg #Astrobiology  #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast  #STEM #Innovation #Technology #Science #ResearchSupport the Show.

A team of three researchers from the Dublin Institute for Advanced Studies (DIAS) will play a key role in the first ever spacecraft attempt to fly past the Moon, and then past Earth. The flyby is set to take place over today and tomorrow (19-20 August). The manoeuvre is part of the European Space Agency (ESA)'s Jupiter Icy Moons Explorer (JUICE) mission. As well as conducting detailed observations of Jupiter and its moons, the mission will be investigating Jupiter's moons as possible habitats for life. The lunar-Earth flyby will be an opportunity for the DIAS team to test their ideas about the spacecraft's behaviour in the environment of a moon, in preparation for the actual flybys of Jupiter's moons. Senior Professor Caitriona Jackman, Dr. Mika Holmberg and Dr. Hans Huybrighs are all members of the DIAS Planetary Magnetospheres Group, which is the only Irish research group involved in the mission. Commenting on DIAS's role in the flyby, Prof. Caitriona Jackman, Associated Scientist and Head of the Planetary Magnetospheres Research Group at DIAS, said "We will be monitoring the flyby with trepidation as it's an extremely challenging undertaking - the slightest mistake could take Juice off course and spell the end of the mission. "This is the first step in Juice's journey through the solar system on its way to Jupiter. The spacecraft will use the gravity of the Moon and then Earth to bend its path through space and redirect it on course for a flyby of Venus in August 2025. This will help to ensure it arrives at Jupiter with the right speed and direction. It's a journey that requires perfect accuracy and in-depth planning." "Having this opportunity to test our ideas about the spacecraft's behaviour in the environment of a moon is truly exciting and will be a huge boost in confidence for our research once Juice arrives at Jupiter. The encounter of Earth's moon is a practice-run for when we get to Jupiter, where we will study moons with underground oceans that might support life. I'm extremely proud of the work carried out by our research group so far, and that we can be part of such an important mission." DIAS expertise DIAS's work on this mission will explore how the spacecraft itself affects the measurement of particles, and will use an advanced computer model to investigate this. Commenting on her involvement in this mission, Dr. Mika Holmberg, Research Fellow at DIAS and Co-Investigator on the Radio and Plasma Wave Investigation Instrument, said, "The measurements from the lunar-Earth flyby could have a significant impact on our research going forward. The effects of the interaction between the spacecraft and its environment influences our interpretation of the measurements. For example, it might change our understanding of where the moon particles that we are trying to detect come from, or how many there are. "The computer simulations account for the environment of the spacecraft and models how the moon particles will be affected, so that we can correct potential misleading effects for later in the mission. When Juice flies by the Moon we have the first opportunity to test our correction techniques during an actual moon encounter, which is exciting. It's the perfect opportunity for us to calibrate our instruments and smooth out any remaining issues, and who knows what it could lead to!" Dr Hans Huybrighs, Research Fellow at DIAS and Associated Scientist of the Particle Environment Package instrument explains that the main objectives of the mission are to study the abilities of Jupiter's moons to host life, which requires accurate and detailed measurements. "Jupiter's moons slowly release particles from their surface. In some cases, this release could happen through water eruptions that produce 100-kilometre-tall plumes. By detecting these particles, we can learn more about the moons' potential to support life. Investigating how Juice can best detect these plumes is one of the topics we are working on at DIAS." DIAS as a l...

In this episode, we dive into the captivating world of cosmic geology with Dr. Kerri Donaldson Hanna, a planetary geologist and Assistant Professor in the Department of Physics at the University of Central Florida. From our Moon to asteroids, Dr. Donaldson Hanna's work centers around airless celestial bodies – or any planetary body in our solar system without an atmosphere. Dr. Donaldson Hanna's research methods are as fascinating as the celestial bodies she studies. She delves into the mysteries of airless bodies through telescopic observations, analysis and interpretation of both telescopic and spacecraft data, and even conducts laboratory measurements using remote sensing data.  Her expertise has been invaluable to various NASA missions, including her roles as a Co-Investigator on the Lunar Reconnaissance Orbiter's Diviner Lunar Radiometer Experiment and a Participating Scientist on OSIRIS-REx. Join us now to learn more about:  What our research about the Moon tells us about its formation.  Insights into the tectonic activity of the Moon and Mars.  Planets within our solar system that are geologically active.  Don't miss the chance to delve deeper into the world of cosmic geology and learn more about the brilliant mind behind it all. Click here now to discover more about Dr. Donaldson Hanna and her exciting work! Take advantage of a 5% discount on Ekster accessories by using the code FINDINGGENIUS. Enhance your style and functionality with premium accessories. Visit bit.ly/3uiVX9R to explore latest collection. Episode also available on Apple Podcast: http://apple.co/30PvU9C

Welcome to another thought-provoking episode of the "I Am Dad" podcast, where we delve into the intricacies of fatherhood, parenting, and family well-being. I'm your host, Kenneth Braswell, and today we are honored to have with us Dr. Cassandra Bolar, a distinguished researcher, educator, and clinical expert whose work has significantly impacted the African American community and beyond. Dr. Bolar's research employs an ecological approach to understand how contextual factors influence father involvement, intimate relationships, and familial functioning within the African American community. She currently serves as a Co-Investigator for the National African American Child and Family Research Center and an Assistant Professor at the University of West Georgia. With a robust clinical passion for serving couples, Dr. Bolar has created the Marriage Head Start premarital curriculum, designed to foster healthy and strong relationships. Her journey also includes pivotal work at Morehouse School of Medicine's Satcher Health Leadership Institute, where she directed three large NIMHD research grants. These grants focused on reducing health disparities among children and families through the Smart and Secure Children program, a quality parenting curriculum. Dr. Bolar holds a bachelor's degree in Child and Family Development from the University of Georgia, as well as master's and doctoral degrees in Human Development and Family Studies from Auburn University. Additionally, she is a Certified Family Life Educator, a credential bestowed by the National Council on Family Relations. In today's episode, we'll explore Dr. Bolar's groundbreaking research, her dedication to relationship education, and the public health implications of her work. We are thrilled to have her share her wealth of knowledge and insights with us. So, sit back and prepare for an enlightening conversation with Dr. Cassandra Bolar on the "I Am Dad" podcast. Welcome, Dr. Bolar!

Yetta Myrick is the mother of a young adult son diagnosed with Autism, ADHD, and Intellectual Disability. She is the Founder and President of DC Autism Parents (DCAP), a 501(c)(3) non-profit organization in the District of Columbia. Ms. Myrick has served as the CDC's Act Early Ambassador to the District of Columbia since 2016, led the DC COVID-19 Response Team from 2020-2022, and is currently leading the DC Act Early Team. In 2022, she co-authored and self-published, "Mr. Marshall's Block Party". Ms. Myrick leads the DC Autism Collaborative's Developmental Monitoring, Screening, and Evaluation Subgroup, co-leads the Family Advisory Group, Outreach and Education Subgroup, and the Community Resources and Support Subgroup. She serves as the Parent Educator/Advocate on the ECHO Autism HUB Team at Children's National Hospital. Ms. Myrick co-leads the “Family Voices United to End Racism Against CYSHCN and Families” Project and served as the Co-Investigator for the “Building Capacity in the African American ASD Community for Patient-Centered Outcomes Research” Project funded through the Patient-Centered Outcomes Research Institute Eugene Washington PCORI Engagement Award. In 2021, she was appointed to the Interagency Autism Coordinating Committee by Secretary of Health and Human Services, Xavier Becerra, J.D. Additionally, Ms. Myrick is a member of the DC Developmental Disabilities Council and was awarded the 2024 Advocate in Equity Award by the DC Developmental Disability Awareness Month Planning Committee. She holds a Bachelor of Arts Degree in Communication Studies from The Catholic University of America.In this special episode, we discuss:PracticeTaking care of yourself to know yourselfBenefits of restResting practicesYoga off the matSelf-studyBoth/AndPurposeSystems of marginalizationNormalizing disabilityConnect with Yetta on her nonprofit's website and download the Rest to Create Change Toolkit.Podcast music by Charles Kurtz+ Read transcript

In this episode of Better Thinking, Nesh Nikolic speaks with Dr Mark Horowitz about exploring expert strategies for tapering off SSRIs and managing withdrawal symptoms. Dr Mark Horowitz MBBS PhD is a Clinical Research Fellow in Psychiatry in the National Health Service (NHS) in England and an Honorary Research Fellow at University College London (UCL) and a trainee psychiatrist. He runs a deprescribing clinic in the NHS helping people to stop psychiatric medications. He co-authored the Royal College of Psychiatry guidance on “Stopping Antidepressants”, and his work informed the recent National Institute for Clinical Excellence (NICE) guidelines on safe discontinuation of psychiatric medications. He also published work on how to safely taper antipsychotics in JAMA Psychiatry and Schizophrenia Bulletin. He has authored chapters of the Maudsley Prescribing Guidelines on how to stop mood stabilisers, antidepressants, antipsychotics, benzodiazepines, z-drugs and gabapentinoids. He is currently writing the Maudsley Deprescribing Guidelines in Psychiatry which will be published in 2023. He is Co-Investigator on the RELEASE trial in Australia evaluating the effect of gradual, hyperbolic tapering of antidepressants compared to care as usual. He has an interest in rational psychopharmacology and deprescribing psychiatric medication. He has experienced the difficulty of coming off psychiatric medications first-hand which has informed much of his work. His work can be found at https://markhorowitz.org/ Episode link at https://neshnikolic.com/podcast/mark-horowitzSee omnystudio.com/listener for privacy information.

Goldilocks, Robin Hood, Little Bess of Bromley, Moll Frith were star performers on the bear baiting circuit in Elizabethan England. New evidence of bear bones uncovered in archaeological digs and over 1,100 accounts in letters and documents from the period, are being studied in a research project called Box Office Bears. Andy Kesson delves into bears' impact on the literary culture of the time and asks if bear baiting was not so much a sporting contest as a staged spectacles akin to contemporary wrestling. Hannah O'Regan explains how bear bones found in archaeological digs in Southwark's theatre land reveal the animals' stressful lives and she suggests that the scary, fighting bears of our cultural imaginary are strikingly different from the playful, conflict defusing bear of real life. Were they unfairly typecast? Hannah O'Regan is Professor of Archaeology and Palaeoecology at the University of Nottingham and Principal Investigator in the BOB Project. She has excavated on sites in the UK, Israel and South Africa. Her current research interests include human-non-human animal interactions (particularly bears). Andy Kesson is a Reader in Renaissance Literature at the University of Roehampton and Co-Investigator in the BOB project. He was the principal investigator for Before Shakespeare, and is working with the theatre maker Emma Frankland on a production of John Lyly's Galatea which he discussed in an episode of Free Thinking called Galatea and Shakespeare https://www.bbc.co.uk/programmes/m001kvpk. He has recently explored a multitude of bears in early modern plays. Box Office Bears: Animal baiting in early modern England, is a project bringing together researchers from the Universities of Nottingham, Roehampton and Oxford and project partner Museum of London Archaeology (MOLA) https://boxofficebears.com/about/ Dr Emma Whipday is a Lecturer in Renaissance Literature at Newcastle University and an expert in Shakespeare, early modern literature, women's history, theatre history, and the history of the home and family . Her current book project, Subordinate Roles, explores the cultural importance of the brother-sister relationship and the place of the unmarried woman in early modern society. She's a BBC/AHRC New Generation Thinker on the scheme which promotes research on the radio. This New Thinking episode of the Arts and Ideas podcast was made in partnership with the Arts and Humanities Research Council, part of UKRI. You can find more in a collection of the website of BBC Radio 3's Free Thinking programme and all available on BBC Sounds.

In this episode of Space Café Radio, SpaceWatch.Global's publisher, Torsten Kriening, has an exciting conversation with Prof Bertrand Goldman, Associate Professor and Research Facilitator of the International Space University and a resident faculty on the Central Campus, about the news from ISU and the new program.Bertrand has contributed as Principal Investigator and Co-Investigator to various observing astronomy projects related to the study of brown dwarfs and ultra-cool dwarfs, the search for Galactic dark matter, and the study of nearby open clusters and moving streams. He served as EU expert for the CoFUND programs, in telescope time allocation committees for the Calar Altar and European Southern Observatories, and chaired the Science Policy Oversight Committee of the Pan-STARRS1 Consortium.The ISU's Master of Science (MSc): Space StudiesThe Master's program in Space Studies is an interdisciplinary program that provides students with the knowledge and skills they need to succeed in the rapidly evolving space sector. The program covers all space domains and a wide range of topics.Graduates of the program will have a deep understanding of space engineering, space applications, space exploration, and the physical and life sciences of the space environment. They will also be familiar with space policies and regulations and will have the ability to critically evaluate knowledge across a variety of disciplines. The program also emphasizes entrepreneurial aspects, preparing students to establish and fund space startups and master project management techniques. If you are interested in a career in the space sector, the Master's program in Space Studies is the perfect program for you.Space Café Radio brings you talks, interviews, and reports from the team of SpaceWatchers while out on the road. Each episode has a specific topic, unique content, and a personal touch. Enjoy the show, and let us know your thoughts at radio@spacewatch.globalPlease visit us at SpaceWatch.Global, subscribe to our newsletters. Follow us on LinkedIn and Twitter!

In this episode, Alex Belser, PhD joins us to discuss how psychedelics can help LGBTQIA+ people heal from bigotry and embracing their identity. After seeing him speak on stage at the Denver Psychedelic Science Convention on the topic of Queering Psychedelics, I knew we needed to have him on Open Deeply along with his co-presenter, Justin Natoli, who was our guest on episode 44. So much was discussed in this episode including how psychedelics can potentially help with the coming out process. And we didn't shy away from the dark history of psychedelics. For instance, did you know that psychedelics have been used unethically in tandem with conversion therapy in attempt to rewire sexual orientation? Horrible, but true. And finally, we discussed what the kink and psychedelic communities can learn from one another. All this and more as once again we dare to Open Deeply. Bio: Alex Belser, PhD is a clinical scientist, author, and licensed psychologist with a focus on psychedelic research. At Yale University, he's a Co-Investigator for a study investigating psilocybin treatment for people with OCD. He has explored the potential of novel therapies using psilocybin, MDMA, ketamine, and DMT to help alleviate human suffering and treat specific indications, including depression, anxiety, addiction, and PTSD. His most recent book: EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person, co-authored with Dr. Bill Brennan, will be published later this year by Oxford University Press. Dr. Belser has co-founded a number of leading psychedelic organizations, including the NYU Psychedelic Research Group in 2006; Nautilus Sanctuary, the first non-profit on the East Coast dedicated to psychedelic medicine; and Adelia Therapeutics, where he served as Chief Clinical Officer (CCO). He also served as CCO at Cybin, where he chaired the Scientific Advisory Board. His other main area of interest is mental health for LGBTQIA+ people—his last book is Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine. His work has been featured in the media, with coverage in the New York Times, the Atlantic, the New Yorker, The Guardian, Forbes, Rolling Stone Magazine, and in Michael Pollan's book, "How to Change Your Mind." Dr. Belser is a hatha and kundalini yoga teacher. He studied at Georgetown, Cambridge, Columbia, NYU, and Yale University. To learn more, you can check out his website at http://alexbelser.com or his practice website, https://www.centerforbreakthroughs.com/ How to find Alex Belser, PhD: Website: https://www.centerforbreakthroughs.com/ Facebook http://facebook.com/alexbelser Instagram http://instagram.com/alex.belser How to find Sunny Megatron: Website: http://sunnymegatron.com Facebook http://facebook.com/sunnymegatron Twitter http://twitter.com/sunnymegatron Instagram http://instagram.com/sunnymegatron Tiktok https://www.tiktok.com/@sunnymegatron YouTube https://www.youtube.com/sunnymegatron American Sex Podcast https://open.spotify.com/show/2HroMhWJnyZbMSsOBKwBnk How to find Kate Loree: Website http://kateloree.com Facebook http://instagram.com/opendeeplywithkateloree Tiktok: https://www.tiktok.com/@opendeeplywithkateloree https://www.facebook.com/kateloreelmft Twitter http://twitter.com/kateloreelmft Instagram http://instagram.com/opendeeplywithKateLoree YouTube https://youtube.com/channel/UCSTFAqGYKW3sIUa0tKivbqQ Open Deeply podcast is not therapy or a replacement for therapy.

Been waiting for a deep dive on the gut-skin-immune axis? We've got it right here. This week, we're joined by Dr. Jason Hawkes as he takes us right into the science behind the many ways in which the body's systems are connected and what that means for treating inflammatory skin diseases. Each Thursday, join Dr. Raja and Dr. Hadar, board-certified dermatologists, as they share the latest evidence-based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Jason E. Hawkes, MD MS is a board-certified dermatologist and Associate Professor of Dermatology at the University of California Davis in Sacramento. He completed his medical degree and dermatology residency training at the University of Utah School of Medicine, where he was also enrolled in the Program's 2+2 dermatology research track. In addition to his clinical training, Dr. Hawkes completed a research fellowship in translation immunology at the National Institutes of Health as part of the HHMI-NIH Research Scholars Program and received a master's degree in Clinical Investigation from Rockefeller University in NYC. Dr. Hawkes' principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, psoriatic arthritis, hidradenitis suppurativa, and eczema. He has a special interest in translational human research and the development of novel biologics and small molecules used for the treatment of inflammatory conditions. Dr. Hawkes is currently serving on the Medical Board of the National Psoriasis Foundation and has served as the Principal Investigator and Co-Investigator of multiple pharmaceutical-sponsored and investigator-initiated clinical trial protocols. He is the recipient of multiple research grants and teaching awards and was recently named the 2021 Outstanding Educator in Psoriatic Disease by the National Psoriasis Foundation. He is the author of more than 50 peer-reviewed publications and 8 book chapters. To learn more about Gut, Immune System, and Inflammatory Skin Diseases, attend Dr. Hawkes' lecture at the 2023 Integrative Dermatology Symposium.

In this week's episode, we have been joined by Glen O'Hara to explore the escalating crisis facing the UK's public services. Over the past 18 months among public services from universities to healthcare the British state has been shaken by waves of strikes and infrastructure breakdowns whose effects have come to be acutely felt in everyday life. With his extensive research background on the history of British state institutions, Glen O'Hara helps us explore the wider social, economic and political dynamics that have brought Britain's public services close to breaking point.As Professor of Modern and Contemporary History at Oxford Brookes University, Glen O'Hara has published groundbreaking work on economic and social policy in Britain after the First World War. He is currently Co-Investigator on the AHRC-funded programme 'Spaces of Hope: The Hidden Histories of Community-Led Planning in the UK' and writes regularly on current affairs and policy for The Guardian and The New European.The background music is by Through the City by Crowander, and the production for this podcast was by Daniel Mansfield.   

In this episode, David interviews Alex Belser, Ph.D.: clinical scientist; author; licensed psychologist; Co-Investigator for a psilocybin and OCD study at Yale University; and co-creator of the EMBARK approach, a new model of psychedelic-assisted therapy that focuses on six clinical domains that typically arise during psychedelic experiences. He is also one of the editors of "Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine," the new anthology from Chacruna featuring 38 essays from queer authors and allies looking at the heteronormative aspects of psychedelic culture and psychedelic-assisted psychotherapy, self-acceptance, psychedelics and pleasure, and ways the queer community can become allies with other groups. As they serendipitously recorded this episode on June 1, it only made sense to celebrate Pride Month by releasing it now, as well as launching a giveaway, where you can win one of five copies of "Queering Psychedelics."  Belser talks about the concurrent emergence of the psychedelic and queer communities; the need to research the effects of transphobia and homophobia in psychedelic work (as well as the internalized phobias often realized during an experience); why it's more important than ever to talk about the psychedelic space's dark past with conversion therapy; why the Mystical Experiences Questionnaire needs to be updated; the idea of queer people being boundary walkers; recreating the Good Friday Experiment, the immense importance of long-form interviews and other forms of qualitative research, the power of love and community, and the question: how does anyone not want to change after a powerful psychedelic experience? www.psychedelicstoday.com

Wondering when to consider JAK inhibitors? We've got just the expert. This week, we're joined by Dr. Jason Hawkes as he outlines just when clinicians should consider implementing JAK inhibitors. Listen in as he talks about the many factors of JAK inhibitor treatments and practical tips for counseling patients on systemic therapies. Each Thursday, join Dr. Raja and Dr. Hadar, board certified dermatologists, as they share the latest evidence based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com. Jason Hawkes, MD MS is a board-certified dermatologist in the greater Sacramento area. He received his medical degree and completed his dermatology residency training from the University of Utah School of Medicine, where he was also enrolled in the Program's 2+2 dermatology research track. Dr. Hawkes then worked as a medical dermatologist as a faculty member in the Departments of Dermatology at the University of Utah, Icahn School of Medicine at Mount Sinai, and University of California Davis. In addition to being a board-certified dermatologist, he completed a research fellowship in translation immunology at the National Institutes of Health (NIH) and received a master's degree in Clinical Investigation from Rockefeller University in NYC.   Dr. Hawkes is currently serving on the Medical Board and Scientific Advisory Committee of the National Psoriasis Foundation (NPF), as well as his role as Councilor in the International Psoriasis Council (IPC). He is the recipient of multiple research grants and teaching awards, including the 2021 NPF Outstanding Educator in Psoriatic Disease. He has served as the Principal Investigator and Co-Investigator of multiple pharmaceutical-sponsored and investigator-initiated clinical trial protocols. He is the author of more than 60 peer-reviewed publications and 10 book chapters. Dr. Hawkes' principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa, and eczema, using novel systemic or biologic therapies.   To learn more about the Interaction of the Immune and Digestive Systems in the Context of Skin Disease, attend Dr. Hawkes' lecture at the 2023 Integrative Dermatology Symposium.

Links from the show:* Knowledge production in higher education: Between Europe and the Middle East* Rate the showAbout my guests:Jan Völkel held teaching and research positions at the Universities of Freiburg and Salzburg, the European University Institute in Florence, Cairo University and Vrije Universiteit Brussel. Besides, he was visiting researcher at Université de Montréal, Dundee University, Bahçesehir Üniversity (Istanbul) and Southern Denmark University (Odense). He participated in various international research activities and won the prestigious Marie-Skłodowska-Curie Fellowship from the European Union for a research project on "Parliaments in the Arab Transformation Processes". He got various stipends and scholarships from the German Academic Exchange Service (DAAD) and has been member of some DAAD selection committees. Since 2008, he has been working as MENA Regional Coordinator at Bertelsmann Transformation Index (BTI, www.bti-project.org).Michelle Pace is Professor in Global Studies at Roskilde University, Denmark. A political scientist by training, her research focuses on the intersection between European Studies, Middle East Studies, Critical Migration Studies, Democratization Studies and Conflict Studies. She is the Danish Lead partner of the Horizon Europe project SHAPEDEM-EU which investigates the EU's practices within its neighbourhoods in a set of policy fields (including migration, as crucial entangled policy areas) to seek out their impact on the effectiveness of its democracy support. She is the Denmark representative on the Management Committee of a COST ACTION network on migration and religious diversity, with a focus on tolerance in today's societies, and alternative epistemologies in the quest for knowledge equity. She has been/is the Principal and/or Co-Investigator on a number of large project grants funded by the Economic and Social Research Council, the Arts and Humanities Research Council, the British Academy, and the Wellcome Trust in the UK, and in Denmark on projects funded by the EU's H2020 as well as the Erasmus+ Programme, the Ministry of Foreign Affairs, and the Carlsberg Foundation. She is currently writing a monograph on Denmark's strict immigration policies, which is funded by a Carlsberg Foundation Monograph Fellowship. Get full access to Dispatches from the War Room at dispatchesfromthewarroom.substack.com/subscribe

Der Südsudan ist der jüngste Staat der Welt. 2011 wurde er nach jahrzehntelangen Kämpfen unabhängig vom Sudan. Von 2013 bis 2018 herrschte erneut Bürgerkrieg. Und nach wie vor kommt es zu Gewalt. Offiziell handelt es sich bei dem ostafrikanischen Staat um eines der ärmsten Länder der Welt. Obwohl der Südsudan eigentlich reich wäre - denn er hat Erdöl. "Der Südsudan ist eines jener Länder, in denen die Diskrepanz zwischen arm und reich besonders groß ist", sagt Südsudan-Experte Jan Pospisil, "70 Prozent der Menschen im Land sind von Nahrungsmittelhilfe abhängig - während sich eine Oberschicht im Ausland Villen leisten kann und sehr teure Autos fährt." Woher rührt der schon jahrzehntelang herrschende Konflikt in der Region? Und welche Hoffnungen lassen sich auf die fürs nächste Jahr geplanten Wahlen setzen? Mit Jan Pospisil, Professor am Centre for Trust, Peace an Social Relations der Coventry University sowie Co-Investigator der Plattform PeaceRep der University of Edinburgh; Edmund Yakani, Menschenrechtsaktivist und Leiter der Organisation CEPO (Community Empowerment for Progress Organisation) sowie Vertreterinnen und Vertretern der Hilfsorganisation Licht für die Welt, die im Südsudan tätig ist.

Dr. Amber Gaffney is a social psychologist and the Principle Investigator of the Social Identity Lab. Her research focuses on social identity, group processes and social influence. She is also an Associate Professor of Social Psychology and Academic Research Graduate Program Coordinator for Cal Poly Humboldt. Stephanie Souter is the Co-Investigator of the Social Identity Lab and is an adjunct faculty member in the Department of Psychology at Cal Poly Humboldt. She is also a Research Analyst III in the office of Institutional Research, Analytics, and Reporting at Cal Poly Humboldt. You can find the Social Identity Lab online (@humboldtsilab.org).   0:00 | The Social Identity Lab and extremism in society   14:32 | Uncertainty and its relation to the group   23:19 | "Othering" people   29:41 | The effect of emotions on collective movements   35:49 | Prototypical vs non-prototypical leaders   47:31 | Group identity vs individual identity   1:00:32 | Well-defined groups vs ambiguous groups   1:09:55 | Social Identity Theory   1:23:22 | Research on the effect of self uncertainty on conspiracy theory adoption   1:30:09 | Nothing is true and everything is possible   1:35:22 | Research vs me-search

Dr. Alex Belser has been a leader in the psychedelic research community for the last twenty years and is an editor of the new book, Queering Psychedelics: From Oppression to Liberation in Psychedelic Medicine.  In this episode we dicuss many of the topics covered in the book that explore the cross section of queer spirituality andpsychedlics. Dr. Belser was an investigator on clinical trials of psilocybin and MDMA to treat depression, anxiety and other issues. He serves as a psychologist and Co-Investigator at Yale and as the Chief Clinical Officer of Cybin where he leads their clinical programs in psychedelic therapeutics. He is also part of Chacruna Institute's Women, Gender Diversity, and Sexual Minorities Working Group.Some of the topics covered include: the ways pychadelic experiences are inherently queer, how folks can work with psychedelics for connecting with their truth and self acceptence, and the queerness of reclaiming our pleasure. Alex also shares some wild stories from the field as an investigator in psychedelic therapy clinical trials and Wil shares personal stories about his expeirences being the only queer person in psychadelic circles. Support the show

With each new wildfire season comes talk that the new season is worse than the last. With recent fires raging in the western u.s., the Australian bush, the Taiga of Siberia, and the forests of France. Many point to climate change as a cause of extreme fires, and scientists are creating more specificated ways of examining that relationship. That is the focus of this episode of Stats+Stories with guest Dr. Jessica McCarty. Dr. Jessica McCarty (@jmccarty_geo) is an Associate Professor of Geography and Director of the Geospatial Analysis Center at Miami University. She has 15 years' experience in applications of geospatial and data science to terrestrial and atmospheric studies. Her expertise includes wildland and prescribed fire, agriculture and food security, land-cover/land-use change, natural resources, and climate change. She has author/co-author of 27 peer-reviewed journal articles, 12 peer-reviewed conference proceedings, 3 book chapters, 4 technical reports, 3 data citations, and 1 NASA Technology Transfer. She has served as Principal Investigator and/or Co-Investigator on NASA, EPA, USDA, and NSF grants on use of remote sensing for prescribed fire, carbon emissions, air quality, LCLUC, and agriculture/food security.

NASA is taking a crash course in defending Earth against a killer asteroid- literally. We've seen how Hollywood does it, but it's now NASA's turn to test how to deflect an asteroid - for real - by slamming a spacecraft into it. The DART mission probe was launched in November towards an asteroid called Didymos and its small moon, Dimorphos. On Tuesday, at 12.14pm NZT, they will finally collide, 11-million kilometres away from Earth. NASA's Co-Investigator on the Impact Working Group Team, Mallory DeCoster, spoke to Morning Report producer Samuel Wat.

South Asians have the highest death rate from heart disease in the U.S. compared to other ethnic groups. Globally, 60% of patients with heart disease are South Asians. Cardiovascular risk in South Asian Americans – Indian, Pakistani, and Bangladeshi immigrant populations – leads to the early onset of plaque in arteries, compared to other groups. That's what the 12-year long Mediators of Atherosclerosis in South Asians Living in America – or MASALA study – has found. And now, the study is expanding to include the children of South Asian immigrants who participated in the first round. This hour on Where We Live, we'll discuss the scope of the study: By 2024, the MASALA cohort will include around 2300 participants in California, Illinois, and New York, whose health will be tracked over the next several decades. The goal? To understand the factors — food, socio-economic determinants, genetics — leading to heart disease in South Asian Americans, how to prevent it, and how to treat it. Findings to date include the link between ectopic fat and cardiac health; a plant diet on heart health; and Coronary artery calcium incidence and changes using direct plaque measurements: The MASALA study.  And, researchers offer Health Tips to South Asians, including a carb counting tool for traditional South Asian foods and healthy vegetarian keto recipes. GUESTS:  Dr. Nilay Shah: Cardiologist and epidemiologist, faculty at the Northwestern University Feinberg School of Medicine. Co-Investigator at the MASALA Study. Krishnendu Ray: Associate Professor of Food and Nutrition Studies, New York University. Author of The Migrant's Table: Meals and Memories in Bengali-American Households. Shraddha Chaubey: Dietitian and Nutritionist, and founder of NutriPledge, LLC. President of the CT Academy of Nutrition and Dietetics.   This show was produced by Sujata Srinivasan, with help from talk show intern Mira Raju.  Where We Live is available as a podcast on Apple Podcasts, Spotify, Google Podcasts, Stitcher, or wherever you get your podcasts. Subscribe and never miss an episode!Support the show: http://wnpr.org/donateSee omnystudio.com/listener for privacy information.

Do you know JAK? If not, then you're about to. This week, we're joined by Dr. Jason Hawkes as he breaks down the specifics of JAK inhibitors, their safety profiles, the JAK-STAT pathway, and more. Each Thursday, join Dr. Raja and Dr. Hadar, board certified dermatologists, as they share the latest evidence based research in integrative dermatology. For access to CE/CME courses, become a member at LearnSkin.com.   Jason Hawkes, MD MS is a board-certified dermatologist and Associate Professor of Dermatology at the University of California Davis in Sacramento. He received his medical degree and completed his dermatology residency training from the University of Utah School of Medicine, where he was also enrolled in the Program's 2+2 dermatology research track. In addition to being a board-certified dermatologist, Dr. Hawkes completed a research fellowship in translation immunology at the National Institutes of Health (NIH) and received a master's degree in Clinical Investigation from Rockefeller University in NYC.   Dr. Hawkes is currently serving on the Medical Board of the National Psoriasis Foundation (NPF) and as a Councilor of the International Psoriasis Council (IPC). He is the recipient of multiple teaching awards and research grants and has served as the Principal Investigator and Co-Investigator of multiple pharmaceutical-sponsored and investigator-initiated clinical trial protocols. He is the author of more than 50 peer-reviewed publications and 8 book chapters. Dr. Hawkes' principal clinical and research interests are the treatment of complex inflammatory skin diseases, such as psoriasis, hidradenitis suppurativa, and eczema, using novel, targeted systemic or biologic therapies.   To learn more about JAK inhibitors and psoriasis, attend Dr. Hawkes' lecture at the 2022 Integrative Dermatology Symposium.

About Connie (in her own words)I am the founder and director of the Women's Reproductive Behavioral Health Division at the Medical University of South Carolina. This division provides integrated mental health and substance use disorder treatment to pregnant and postpartum women in obstetric and pediatric settings, affords clinical and clinical research training in Reproductive Psychiatry and conducts clinical research that aims to improve the identification and treatment of peripartum mental health and substance use disorders. I receive research support through the National Institute of Health and foundations to develop treatments to improve women's health. Additionally I am a Co-Investigator on the Intern Health Study – a large prospective study examining stress and depression among medical trainees. I have published widely on topics including women's health, stress, and depression.https://www.linkedin.com/in/guille-constance-35552060/https://web.musc.edu/

South Asians have the highest death rate from heart disease in the U.S. compared to other ethnic groups. Globally, 60% of patients with heart disease are South Asians. Cardiovascular risk in South Asian Americans – Indian, Pakistani, and Bangladeshi immigrant populations – leads to the early onset of plaque in arteries, compared to other groups. That's what the 12-year long Mediators of Atherosclerosis in South Asians Living in America – or MASALA study – has found. And now, the study is expanding to include the children of South Asian immigrants who participated in the first round. This hour on Where We Live, we'll discuss the scope of the study: By 2024, the MASALA cohort will include around 2300 participants in California, Illinois, and New York, whose health will be tracked over the next several decades. The goal? To understand the factors leading to heart disease in South Asian Americans, how to prevent it, and how to treat it. Findings to date include the link between ectopic fat and cardiac health; a plant diet on heart health; and Coronary artery calcium incidence and changes using direct plaque measurements: The MASALA study.  And, researchers offer Health Tips to South Asians, including a carb counting tool for traditional South Asian foods and healthy vegetarian keto recipes. This show was produced by Sujata Srinivasan, with help from talk show intern Mira Raju.  GUESTS:  Dr. Nilay Shah: Cardiologist and epidemiologist, faculty at the Northwestern University Feinberg School of Medicine. Co-Investigator at the MASALA Study. Krishnendu Ray: Associate Professor of Food and Nutrition Studies, New York University. Author of The Migrant's Table: Meals and Memories in Bengali-American Households. Shraddha Chaubey: Dietitian and Nutritionist, and founder of NutriPledge, LLC. President of the CT Academy of Nutrition and Dietetics.  Support the show: http://wnpr.org/donateSee omnystudio.com/listener for privacy information.

In this episode, Dr. Andrew Cutler interviews Dr. Tiffany Greenwood about the intersection of genetics, personality traits, temperament and cognitive traits in bipolar disorder and creativity. What is psychiatric genetics? What is known about dopamine's role in creativity? Dr. Tiffany Greenwood address these questions and much more. Dr. Greenwood received her B.S. in Molecular Biology and her Ph.D. in Biomedical Sciences from UC San Diego, with an emphasis in psychiatric genetics. She then augmented her molecular genetic background with postdoctoral training in applied statistical genetics and acquired supplemental training in clinical psychopathology through a Career Development Award from the National Institute of Mental Health (NIMH). She joined the Department of Psychiatry at UC San Diego in 2007 and is currently an Associate Professor. As the Director of the Laboratory for Psychiatric Spectrum Research, Dr. Greenwood's research focuses on the use of dimensional and intermediate phenotypes, as well as clinical subphenotypes, to reduce clinical heterogeneity and refine the genetic signal. Such measures provide increased specificity, both within and across diagnostic categories, as well as a better reflection of the underlying biological processes. In this vein, Dr. Greenwood participates in a number of large-scale collaborations aimed at identifying genetic risk variants for psychiatric illness, including the Consortium on the Genetics of Schizophrenia (COGS), the Bipolar Genome Study (BiGS), and the Psychiatric Genomics Consortium (PGC). Her research in this area has been supported by a NARSAD Young Investigator Award for the development and utilization of a customized candidate gene array for schizophrenia and related phenotypes, as well as a K01 from the NIMH aimed at quantifying and interpreting the overlapping and unique aspects of bipolar disorder and schizophrenia. Dr. Greenwood has served as a Principal Investigator or Co-Investigator on a number of University and NIH-funded grants, including a current study exploring bipolar disorder as a dimensional phenotype existing at the extreme of normal population variation in positive traits, such as temperament, personality, creativity, and cognitive flexibility. Dr. Greenwood also recently received funding for a pilot project to implement a comprehensive screening and risk assessment program at UC San Diego. This project aims identify behavioral, environmental, and genetic factors associated with risk for mental health conditions, particularly mood disorders and suicide, and develop a risk prediction model to be used for early intervention. With this special series, brought to you by the NEI Podcast we will address a different theme in psychopharmacology every 3 months. Each theme is split into 3 parts, with one part released each month. This theme is on practical psychopharmacology. Episodes to be released under this theme include: Part 1: The Lightning in the Storm: Creativity in Bipolar Disorder Part 2: Nikola Tesla's Evil Twins: Genius and Madness with Marko Perko Part 3: History of Creative Famous Individuals with Bipolar Disorder Subscribe to the NEI Podcast, so that you don't miss another episode!

The third Season of the National Institute of Neurological Disorders and Stroke's Building Up the Nerve podcast helps you strengthen your mentoring relationships with tools and advice from both trainees and faculty. We know that navigating your career can be daunting, but we're here to help—it's our job!In the first episode of the season, we will set the stage by defining who a mentor is and discussing different types of mentoring relationships, and mentoring models.Featuring Claire Horner-Devine, PhD, Co-Investigator of BRAINS and Founder, Counterspace Consulting LLC; Fátima Sancheznieto, PhD,  Assistant Researcher, University of Wisconsin-Madison, Institute for Clinical and Translational Research (ICTR); and Corey Welch, PhD, Director, STEM Scholars Program, Iowa State University.ResourcesBroadening the Representation of Academic Investigators in NeuroScience (BRAINS): https://brains.uw.edu/ Society for the Advancement of Chicanos/Hispanics and Native Americans in Science (SACNAS): https://www.sacnas.org/ National Academies report on "The Science of Effective Mentorship in STEMM:" https://www.nationalacademies.org/our-work/the-science-of-effective-mentoring-in-stemm#sectionPublications Fátima Sancheznieto's TedxChicago talk "How to keep the next generation of brilliant scientists:" https://www.youtube.com/watch?v=EmwkDW3-99gThe Inigo Montoya Method: https://lifehacker.com/introduce-yourself-like-inigo-montoya-1840314386UC Berkeley Biology Scholars Program (mentioned by Dr. Corey Welch): https://bsp.berkeley.edu/ Transcript available at http://ninds.buzzsprout.com/.

Creativity is such a big part of life, however, it's often overlooked in a school environment. Kate Robinson and Dr. Penny Hay are on a mission to change this. Kate Robinson is a writer, speaker, and co-founder of a number of initiatives dedicated to the legacy of her father, Sir Ken Robinson. She works as an international consultant in creativity and innovation in education. Kate's expertise lies in raising the profile of inspiring initiatives, with a particular focus on startups and building strong partnerships with a social purpose. Her passion lies in engaging youth voices, and through this work has been awarded for Outstanding Contribution to Education Empowerment.Dr. Penny Hay is a Research Fellow at the Centre for Cultural and Creative Industries and Reader in Creative Teaching and Learning and Senior Lecturer in Arts Education, School of Education Bath Spa University; Director of Research, House of Imagination.Penny's doctoral research focused on children's learning identity as artists. She is a Co-Investigator on the AHRC Global Challenges Research project ‘Rethinking waste: Compound 13 Lab' in Mumbai. Penny is also a visiting Lecturer at Plymouth College of Art, National Teaching Fellow, and Fellow of the Chartered College of Teaching, with awards from Action for Children's Arts and Creative Bath.Let's keep the inspiring discussion going! Discover our events, articles, and more with these links:InspirEd MagazineInspirEd EventsJoin our mailing listYou Tube

Dr. Eric Garland, PhD, LCSW is Distinguished Endowed Chair in Research, Distinguished Professor, and Associate Dean for Research in the University of Utah College of Social Work, Director of the Center on Mindfulness and Integrative Health Intervention Development (C-MIIND), and Associate Director of Integrative Medicine in Supportive Oncology and Survivorship at the Huntsman Cancer Institute. Drawing from more than 15 years of clinical experience as a psychotherapist, Dr. Garland is the developer of an innovative mindfulness-based therapy founded on insights derived from cognitive neuroscience, called Mindfulness-Oriented Recovery Enhancement (MORE). As Principal Investigator or Co-Investigator, he has received more than $60 million in research grants from a variety of prestigious entities including the National Institutes of Health (NIH) and the Department of Defense (DOD) to conduct clinical trials to develop and test novel integrative health interventions, including trials of MORE as a treatment for addiction and chronic pain.  Dr. Garland is arguably the world's leading expert on the use of mind-body therapies to address opioid misuse and addiction among people with chronic pain. In a recent bibliometric analysis of mindfulness research published over the past 55 years, Dr. Garland was found to be the most prolific author of mindfulness research in the world. Visit www.drericgarland.com Link to clinical training in Mindfulness-Oriented Recovery Enhancement: https://drericgarland.com/training-in-more/

On this episode, Mariah Heller sits down with Professor Lara Bloom to discuss Ehlers Danlos, Chronic Pain, and "Invisible Ilnesses" to dig deeper into WHY these issues have been so heavily neglected by the healthcare system, and WHAT we can do about it. Tune in for a conversation with an incredible person doing incredible things. Lara Bloom is the President and CEO of The Ehlers-Danlos Society and responsible for globally raising awareness of rare, chronic and invisible diseases, specialising in the Ehlers-Danlos syndromes, hypermobility spectrum disorders (HSD) and related disorders. Before joining the Ehlers-Danlos Society Lara ran EDS UK from 2010-2015. Lara regularly works with umbrella organisations lobbying at government level internationally. In addition to her role as President and CEO of The Ehlers-Danlos Society, she is the Global Ambassador for Global Genes and Advocacy Committee Member for Rare Diseases International, Co-Investigator in the NIHR CONCORD: CO-ordiNated Care Of Rare Diseases, Expert Advisor in the European Reference Network Groups RECONNECT & VASCERN, Expert Advisor to PARADIGM & EPF, Working Group Member of the GenTAC Alliance Patients, Families, and Clinicians, and a Patient Group Consultative Forum Member for the Medicines and Healthcare Products Regulatory Agency. Commemorating ten years in the field of patient advocacy for the Ehlers-Danlos syndromes (EDS), hypermobility spectrum disorders (HSD), chronic illnesses, and rare diseases, Lara was officially appointed a Professor of Practice in Patient Engagement and Global Collaboration at Penn State College of Medicine, USA, on March 11, 2020. Website: www.ehlers-danlos.com Website 2: www.larabloom.com LinkedIn: https://www.linkedin.com/in/larabloom/?originalSubdomain=uk Instagram: @lara.bloom and @ehlers.danlos

In this episode, I had the honor of speaking with Dr. Nathaniel Chin about Aducanumab/Aduhelm the new FDA approved Alzheimer's drug. Dr. Chin is an assistant professor in the division of geriatrics and gerontology. Dr. Chin received his undergraduate and medical degrees from the University of Wisconsin-Madison. He then went to the University of California-San Diego for his internal medicine residency. After completing his residency he spent the next two years working as a Hospitalist for Kaiser Permanente before returning to WI in 2015 to help his mother provide care for his father who had been diagnosed with Alzheimer's disease. He completed his geriatric fellowship in 2016 and spent another year in a dementia research fellowship within geriatrics. He was then hired as an assistant professor. Dr. Chin sees patients in the UW Health Memory Clinic and in addition to providing diagnoses he focuses on palliative care in chronic disease management. In addition to his clinical and research work, he is the medical director of the WI Alzheimer's Disease Research Study and the Wisconsin Registry for Alzheimer's Prevention Study, the Co-Leader of the ADRC Clinical Core, as well as the Associate Director of the Geriatric Memory Clinics at UW-Health. He also serves on the board of the WI Alzheimer's Association and the Alzheimer's Foundation of America. Dr. Chin is a Co-Investigator on 5 NIH grants, with one of them focused biomarker disclosure. He presents frequently on the topics of AD and geriatrics and in the past 3 years has given over 55 presentations at local, regional and national conferences. He has created over 100 podcasts on AD research and caregiving topics under his podcast called Dementia Matters.  Please tune in for a great learning session on this new drug and more.

This podcast is about big ideas on how technology is making life better for people with vision loss. Today's big idea centers on the place where big ideas get born — the human brain. In today's episode, Dr. Roberts and his guests explore theories of brain plasticity, sensory substitution, and sensory augmentation. Dr. Patricia Grant discusses the BrainPort, which uses sensory substitution in this case, the nerve fibers in the tongue, to send information to the brain instead of the optic nerve. Dr. John-Ross Rizzo is developing a device to be called the Sensory Halo, which is supported by sensory augmentation. Both guests share what is being learned about sensory substitution and augmentation through these technologies and how this understanding will help perfect future devices to enable people with vision impairment to see better.   The Big Takeaways: The BrainPort is a headset device with a camera that picks up visual input as the eyes would. It uses the theory of sensory substitution by sending stimulation to the nerve fibers on the tongue. The device picks up visual formation in grayscale imagery: lighter areas of the images produce high stimulation on the tongue, while dark areas produce none. This contrast allows users to identify objects in their environment. The BrainPort device is meant for people who are blind so it's not crowding out a person's residual vision. And surprisingly, both users who are congenitally blind and users who have seen before and have a visual memory — have performed the same in clinical trials.  This shows that users are not experiencing a memory of sight. They are learning to interpret the camera's image through stimulating the nerve fibers on their tongue. In the future, there are opportunities for collaboration between BrainPort and other technologies to continue to enhance the user experience to create more autonomy. Another device being developed that draws on some aspects of sensory augmentation is the Sensory Halo. Using a device with sensory augmentation is more intuitive to use than a device that uses sensory substitution. The Sensory Halo is designed to empower the wearer by delivering key pieces of information to safely and independently navigate their environment.   Tweetables: “We put the brain port on him and started training him, and we were doing some mobility tasks...And I was walking around the room and he would just scan the room. Then all of a sudden, I could feel when he perceived me.” — Dr. Patricia Grant “The great thing about the BrainPort is that it gives a person their own sense. It's something that they can experience on their own, and that is of great value to a person who is blind.” — Dr. Patricia Grant “Simply put, I just want to amplify your existing senses and augment what I can give to you right now so that you can have a richer experience.” — Dr. John-Ross Rizzo   Contact Us: Contact us at podcasts@lighthouseguild.org with your innovative new technology ideas for people with vision loss.   Pertinent Links: Lighthouse Guild BrainPort Assistive Technology & Advanced Wearables by John-Ross Rizzo, MD, MSCI   Guest Bios: Patricia Grant, PhD, Director of Clinical Research, Wicab, Inc. Dr. Grant joined Wicab, Inc. as Director of Clinical Research in February 2014. She previously served as Co-Investigator for Wicab's FDA clinical trial and currently serves as the Principal Investigator of a clinical trial, funded by the US Department of Defense, investigating the safety and efficacy of the BrainPort for people who have been blinded by traumatic injury. Her future research goals include demonstrating the value of the BrainPort in the workplace, in addition to teaching spatial concepts to children. Prior to joining Wicab, Dr. Grant was the Director of Research at the Chicago Lighthouse for People Who Are Blind and Visually Impaired and a Research Specialist in the Low Vision Research and the Applied Physics laboratories in the Department of Ophthalmology & Visual Sciences at the University of Illinois at Chicago. In addition to her work at Wicab, Dr. Grant has contributed to research in the areas of methods for assessing loss of vision due to retinal disease, treatments to optimize remaining vision, the psychological effects of vision loss, and the measurement of retinal image quality and ocular aberration. She earned a BA in Psychology, an MS in Public Health Sciences, and PhD from the School of Public Health at the University of Illinois at Chicago, with a concentration in behavioral science and eye health promotion.   John-Ross (JR) Rizzo, MD, MSCI, Director of Innovation and Technology, Assistant Professor Department of Rehabilitation Medicine and Department of Neurology, NYU Langone Medical Center John-Ross (JR) Rizzo, MD, MSCI, is a physician-scientist at NYU Langone Medical Center. He is serving as the Director of Innovation and Technology for the Department of Physical medicine and rehabilitation at Rusk Institute of Rehabilitation Medicine, with cross-appointments in the Department of Neurology and the Departments of Biomedical & Mechanical and Aerospace Engineering New York University Tandon School of Engineering. He is also the Associate Director of Healthcare for the NYU Wireless Laboratory in the Department of Electrical and Computer Engineering at New York University Tandon School of Engineering. He leads the Visuomotor Integration Laboratory (VMIL), where his team focuses on eye-hand coordination, as it relates to acquired brain injury, and the REACTIV Laboratory (Rehabilitation Engineering Alliance and Center Transforming Low Vision), where his team focuses on advanced wearables for the sensory deprived and benefits from his own personal experiences with vision loss. He is also the Founder and Chief Medical Advisor of Tactile Navigation Tools, LLC, where he and his team work to disrupt the assistive technology space for those with visual impairments of all kinds, enhancing human capabilities. He partners with a number of industrial sponsors and laboratories throughout the country to help breakthrough new barriers in disability research and/or motor control.   Host Bio: Dr. Calvin W. Roberts Calvin W. Roberts, MD, is President and Chief Executive Officer of Lighthouse Guild, the leading organization dedicated to providing exceptional services that inspire people who are visually impaired to attain their goals. Dr. Roberts has a unique blend of academic, clinical, business, and hands-on product development experience. Dr. Roberts is a Clinical Professor of Ophthalmology at Weill Cornell Medical College. He was formerly Senior Vice President and Chief Medical Officer, Eye Care, at Bausch Health Companies where he coordinated global development and research efforts across their vision care, pharmaceutical, and surgical business units. As a practicing ophthalmologist from 1982 to 2008, he performed more than 10,000 cataract surgeries as well as 5,000 refractive and other corneal surgeries. He is credited with developing surgical therapies, over-the-counter products for vision care, prescription ocular therapeutics, and innovative treatment regimens. He also holds patents on the wide-field specular microscope and has done extensive research on ophthalmic non-steroidals and postoperative cystoid macular edema. Dr. Roberts has co-founded a specialty pharmaceutical company and is a frequent industry lecturer and author. He currently serves as an Independent Director on multiple corporate boards and has served as a consultant to Allergan, Johnson & Johnson, and Novartis. A graduate of Princeton University and the College of Physicians and Surgeons of Columbia University, Dr. Roberts completed his internship and ophthalmology residency at New York-Presbyterian Hospital/Columbia University Medical Center in New York. He also completed cornea fellowships at Massachusetts Eye and Ear Infirmary and the Schepens Eye Research Institute in Boston.

In this episode of Why Change?co-hosts Rachael and Jeff discuss their relationship and how colleagues can help each other dive deep on topics, to expand their perspectives. Rachael interviews Penny Hay, a creativity scholar and organizational leader in the UK. They discuss the role of creativity in social movements and how to work on systems change to reimagine education. Rachel and Jeff debrief with a passionate dialogue about the role of creativity in the world - like creative justice - and how definitions don't matter. In this episode you'll learn: How creativity can be used in reforming education systems; What creative justice looks like as part of social movements; and Why definitions don't matter, but systems change does. Please download the transcript here. ABOUT PENNY HAY- An artist, educator, Reader in Creative Teaching and Learning, Senior Lecturer in Arts Education, School of Education; Research Fellow, Centre for Cultural and Creative Industries; Bath Spa University and Director of Research, House of Imagination. Signature projects include School Without Walls and Forest of Imagination. Penny is also a co-founder of Bath Cultural Education Partnership. Penny's doctoral research focused on children's learning identity as artists. She is Co-Investigator on the AHRC Global Challenges Research project ‘Rethinking waste: Compound 13 Lab' in Mumbai. Penny is a visiting Lecturer at Plymouth College of Art and co-designed their MA in Creative Education. Penny coordinates the South West Creative Education Hub, is strand leader for Creative Pedagogy in the Policy, Pedagogy and Practice Research Centre, Associate Director of TRACE at Bath Spa University and a member of the Paper Nations Advisory Group. She is on the Steering Group of the APPG for Art Craft and Design Education and on the Advisory Groups for the Cultural Learning Alliance, HundrED (Finland), Crafts Council Learning and Development and a member of the RSA Innovative Education Network. Penny is co-chair of What Next? West and co-host of the RSA Bath Network. Penny regularly speaks regularly at international conferences and is part of the UNESCO Futures of Learning Group. She is working internationally in Europe, Scandinavia, India, Zimbabwe and Canada. Penny was awarded by Action for Children's Arts for her contribution to arts education and by Creative Bath for her work in creative education. WHERE TO FIND PENNY: -@PenAHay -@houseimaginatn -@forestimaginatn -@schwithoutwalls This episode of Why Change? A Podcast for the Creative Generation was powered by Creative Generation. Produced and Edited by Daniel Stanley. For more information on this episode and Creative Generation please visit the episode webpage and follow us on social media @Campaign4GenC --- Support this podcast: https://anchor.fm/whychange/support

Dr. Alex Belser, the Chief Clinical Officer at Cybin, has been a leader in psychedelic research for 20 years. His resume includes serving as an investigator in clinical trials of psilocybin and MDMA as well as being a Co-Investigator at Yale University, one of his five alma matters. He also studied at Georgetown University, The University of Cambridge, Columbia University, and NYU. Today, he and host Sherry Walling take a deep dive into the intersection between the LGBT and psychedelic research communities including: What Queering Is (2:00 – 3:52) The Overlap and Exclusion of the LGBT and Psychedelic Research Communities (3:52 – 10:29) Reckoning with the History (10:30 – 14:06) How to Make The Room Safer (14:07 – 16:23) The Scientific Factoring of Joy (16:24 – 20:33) End-Of-Life Anxiety (20:34 – 25:01) Psychedelics and Suicide Prevention Among LGBT Youth (25:02 – 29:23) His writing is available at http://alexbelser.com. His private practice site is http://centerforbreakthroughs.com.

Dr. Morgan Cable is the Ocean Worlds Program Scientist for the Planetary Mission Formulation Office, and the supervisor of the Astrobiology and Ocean Worlds Group at the NASA Jet Propulsion Laboratory in Pasadena, California. She worked on the Cassini Mission as a Project Science Systems Engineer, and is currently a Co-Investigator on the Dragonfly Mission to Saturn's moon Titan and a Collaborator on the Europa Clipper Mission. --- Send in a voice message: https://anchor.fm/bigedidea/message

Welcome to The Barrier Breakdown: Disrupting Mental Health!  This week our guest is Dr. Samuel Chawner, a research fellow from Cardiff University's Center for Human Developmental Science. His reasearch integrates genetics and psychology to provide new insights into child development and autism. Rather than disgnosing autism purely on symptoms, Dr. Chawner's studies use genetic testing to produce a more inclusive diagnostic procedure that aims to help individuals who don't meet the criteria for autism but still need help. We also discuss the effects of Covid-19 in Europe and the UK, as well as some of the differences between the US healthcare system and the European model.  You can find Dr. Chawner's Cardiff University staff page as well as links to his publications here: https://www.cardiff.ac.uk/people/view/2422703-  His work with the Genes to Mental Health Network, where he is a Co-Investigator on Project 2, is also available here: https://genes2mentalhealth.com/  All our upcoming continuing education events can be found at www.cbicenterforeducation.com  You can watch or listen to The Barrier Breakdown on any of the following streaming services: YouTube - https://www.youtube.com/channel/UCyc6xZzY7ra3L5pI2g5GKrw   Podbean - https://cbi.podbean.com Spotify - https://open.spotify.com/show/2ETgUdDykWN96Tv26PWyZ2   Apple Podcasts - https://podcasts.apple.com/us/podcast/the-barrier-breakdown-disrupting-mental-health/id1546097545   Follow us on social media: CBI: https://www.facebook.com/CognitiveBehaviorInstitute  Center for Ed: https://www.facebook.com/CBIcenterforeducation  Instagram: @cognitivebehaviorinstitute  Twitter: @CBI_Pittsburgh :::::::::::::::::::: Music: Basic Majesty - Ashley Shadow Support by RFM - NCM: https://youtu.be/XVwlTTMgw5c   ::::::::::::::::::::

Dr. Angus Lockyer detonates bids to define imperial Japan's historical and artistic identities, through Niiro Chunosuke's 1930s replica of the Kudara Kannon. 6000 miles from home, in the British Museum, stands one of two replicas of a Japanese national treasure. But most visitors pass her by, in search of samurai armour, elegant pottery, and woodblock prints. Though carved in Japan, the original and replicas of the Kudara Kannon tell us much about the archipelago's relationship with the Asian continent and the wider world. Used over the centuries to cement power and identity, the Kudara Kannon shows us how even the proudest empires depend on ideas from elsewhere. PRESENTER: Dr. Angus Lockyer, Visiting Scholar in the Center for Asian Studies at the University of Colorado Boulder. He formerly taught Japanese, East Asian, and global history at SOAS University of London (2004-2019), and was a Co-Investigator in the SOAS-British Museum research project, Late Hokusai: Thought, Technique, Society. ART: Replica of the Kudara Kannon, Niiro Chunosuke (1931-1932). IMAGE: ‘Replica of Bodhisattva Kudara Kwannon figure, made of painted wood'. SOUNDS: Pauline Oliveros, Miya Masaoka. PRODUCER: Jelena Sofronijevic. Follow EMPIRE LINES at: twitter.com/jelsofron/status/1306563558063271936 Support EMPIRE LINES on Patreon: patreon.com/empirelines